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ABSTRACT 
NANOPARTICLE BUILDING BLOCKS  
FOR FUNCTIONAL STRUCTURES 
 
SEPTEMBER 2014 
 
YOUNGDO JEONG, B.A., HANYANG UNIVERSITY 
 
M.A., HANYANG UNIVERSITY 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Vincent M. Rotello 
 
 
A major goal in material science is achieving a desired function using 
structures fabricated with designed building blocks. Advanced synthetic and self-
assembly techniques allow various nanomaterials to become promising building 
blocks, providing the control of the interaction between building blocks. The unique 
properties of nanomaterials can be transferred to structured systems. Among 
nanomaterials, inorganic nanoparticles such as gold nanoparticles (AuNPs), 
magnetic particles, and quantum dots (QDs) provide useful physical properties 
stemming from their inorganic core, large surface areas, and oriented surface 
functionalities. My research has focused on fabricating functional systems using 
gold nanoparticles (AuNPs), manipulating the interaction between AuNPs, bio-
entities, and small molecules. To construct complicated three-dimensional structures 
and embed functions, emulsion templates for the fabrication of the capsule structures 
and various supramolecular chemistry between AuNPs or AuNP and enzyme were 
employed. My research consisted of 2 approaches: first, through both the design of 
	  vii 
the monolayer at the molecular level and the emulsion template, (1) enzyme-
immobilized microparticles having high immobilization efficiency and reusability 
were fabricated;  (2) correlations between the mechanical properties of the AuNP 
monolayer film and the binding affinities between nanoparticle components were 
investigated; and (3) stable 100 nm sized nanoparticle-dendrimer hybrid capsules as 
a drug delivery carrier were fabricated and evaluated in vivo. Second, by 
encapsulating various hydrophobic catalysts in the hydrophobic pockets of the 
monolayer of water-soluble AuNPs, (4) water-soluble nanoreactors were developed. 
By incorporating host-guest elements on the surface of water-soluble nanoreactors, 
(5) artificial enzymes capable of catalyzing bio-orthogonal chemical reactions inside 
living cells which can be regulated by the addition of host or guest molecules were 
fabricated.  As can be seen, engineering of the AuNP surface at the molecular level 
opens new avenues for the fabrication of numerous functional materials.  
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CHAPTER 1 
NANOPARTICLES AS BUILDING BLOCKS 
 1.1 Introduction 
Nanoparticles provide useful building blocks for the fabrication of functional 
structures, implanting their unique properties in self-assembled structures.1 Monolayer-
protected inorganic nanoparticles have particularly been employed in material science via 
control of their surface functionalities.2 Nanoparticles represent hybrid systems of nano-
scale metal cores covered by self-assembled monolayers of organic ligands. The use of 
nanoparticles as building blocks takes advantage of both the dimensions and the physical 
properties of the inorganic core, as well as the functions of the organic surface periphery. 
Nanoparticles exhibit a number of unique physical and chemical properties 
relative to bulk material. The distinctive properties of nanoparticles include their 
enormous surface area, oriented functionalities, and structures having a rigid core and 
soft monolayer. Additionally, the tunable properties of nanoparticles –their components, 
size, shape, and functionalized surface have made them attractive building blocks in   
various material fabrications, including electronic and optical devices, chemical and 
biological sensor platforms, cell labeling and imaging, and cancer therapy.3  
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Figure 1.1 Schematic illustrations of monolayer-protected gold nanoparticles: an 
inorganic gold core protected by an organic monolayer that can control a myriad of 
interactions between many other building blocks.  
 
 Functionalization of gold nanoparticles (AuNPs) is achieved by a Murray place-
exchange reaction 4  with appropriate functional ligands. Incorporation of multiple 
functionality within the scaffold of a single particles coupled with a scale comparable with 
biomacromolecules (e.g. proteins and DNA), other particles, and small molecules provides 
multiple applications for functional self-assembled structures.  For example, intricately 
designed structures have been fabricated using DNA origami strategies and DNA 
functionalized AuNPs.5 Furthermore, colloidal micro/nano capsule structures have also 
been  developed through using surface functionalized AuNPs and oil/water interfaces for 
delivery vehicles,6 high-throughput template for analysis7 and fabrication of inorganic 
protocells.8 This thesis work utilized AuNP as a building block for the fabrication of 
various functional structures.   As background to this work, self-assembly of functionalized 
AuNPs, fabrication of stable colloidal microcapsules, and supramolecular interaction 
between small molecules and the monolayers of AuNPs will be discussed in this chapter. 
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1.2 Self-assembled structures using nanoparticles 
 To embed various functions such as catalytic ability or mechanical strength into 
AuNP-involved self-assembled structures, one must understand the interaction of AuNPs 
with various materials such as proteins, polymers, and small molecules possessing 
desirable functions.  That the functionalities of AuNPs can be easily modified through a 
large number of ligands and the functionalities have orientation is key to dictate the 
processes in self-assembly. Therefore, proper design of the interaction between those 
materials and AuNPs allows construction of intended self-assembled structures with 
desirable functions.  
Various supramolecular interactions including electrostatic attractions,9 hydrogen 
bonding,10 pi-pi stacking and van der Waals interactions11 between nanoparticle and 
proteins have been designed to control nanoparticle self-assemblies. Rotello et al. have 
developed a  ‘chemical nose’ sensing system using functionalized nanoparticles and their 
various interactions. 12  Specific signal patterns of this system can be obtained for 
identifying proteins, controlling the affinities between the various functionalized AuNPs 
and proteins. Using the self-assembly of negative charged AuNPs and α-Chymotrypsin, 
the catalytic activities of α-Chymotrypsin were modulated.13 In this study, the charge-
charge interaction between AuNPs and substrates can control the diffusion rate of the 
substrate allowing it to enter the active site of the enzyme.  
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Figure 1.2 Schematic illustration of a “chemical nose” sensor array based on AuNP-
fluorescent polymer/GFP conjugates. (a) Competitive binding between protein and 
quenched polymer-AuNP complexes leads to the restoration of fluorescence (b) 
Combination of an array of sensors generates fingerprint response patterns for individual 
proteins. (c) Competitive binding between protein and nanoparticle−GFP complexes 
leads to fluorescence light-up. (Adapted from ref.12d )  
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Figure 1.3 (a) Molecular structure of α-chymotrypsin. (b) Chemical structure of amino-
acid-functionalized gold nanoparticles and SPNA-derived substrates. (c) Schematic 
representation of monolayer-controlled diffusion of the substrate into, and the product 
away from the active pocket of nanoparticle bound α-chymotrypsin. (Adapted from ref.13) 
 Various covalent bonds between AuNPs have been developed for the fabrication 
of stable nanoparticle composite films in various areas. Chemoselective nanoporous 
membranes,14 drug-release controlling films,15 and chemical responsive films16 have been 
fabricated using a direct covalent assembly of AuNPs and polymers. Using covalent 
chemistries between cores and polymers or the functional group of AuNPs and polymers, 
desirable properties and structures of films such as mechanical strength and porosity can 
be achieved.       
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1.3 Fabrication of stable nanoparticle-based colloidal microcapsules 
In recent years, there has been increasing interest in the fabrication of 
microcapsules (MCs) due to their widespread applications as delivery vehicles, 
microreactors, catalyst supports and encapsulants.17 Their small size, large surface area, 
large inner volume, high stability and oftentimes stimuli-responsiveness make them an 
ideal platform for drug encapsulation and delivery. Until recently, utilization of 
nanoparticles (NPs) as the principal building blocks of MCs has been limited due to 
challenges in obtaining stable MCs.  
The focus of this chapter is highlighting recent advances in the fabrication of 
stable colloidal MCs where NPs are used as building blocks. In general, these MCs are 
fabricated using emulsion-templating in which a liquid-liquid microemulsion is utilized 
to self-assemble colloidal micro/nanoparticles at the interfaces. While there are numerous 
reports of fabrication of large MCs using colloidal particles that are in the micron to 
submicron size range, it is only in recent years that fabrication of MCs with NP building 
blocks have been realized. Incorporation of colloidal NPs as building blocks expands the 
functional capabilities of MCs by contributing of various attributes inherent to the NPs 
due to their nanoscale dimensions. For example, the utilization of plasmon-active NPs 
such as gold and magnetically active NPs such as iron-oxide can enable fabrication of 
MCs responsive to external triggers such as laser and magnetic fields, respectively.18 
Proper selection of ligands on NP surfaces, inter-particle linkages or crosslinking 
strategies would allow tuning the properties of colloidal MCs including permeability, 
mechanical stability, biocompatibility, electric properties, and stimuli responsiveness. 
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While emulsion-templating can be employed to obtain MCs composed of NPs, it 
is important to stabilize these MCs, thereby providing stability that can overcome thermal 
disorder to these colloidal assemblies allowing products for practical applications. 
Control over the assembly process at both the micro- and nanoscopic level would allow 
fabrication of stable MCs.19 NPs with an appropriate ligand shell can be employed to 
provide stability of the self-assembled MCs via either covalent or non-covalent 
interactions. In the next sections, a short introduction to the factors affecting the stability 
of the emulsion based colloidal MCs is followed by examples from recent literature 
providing a glimpse of the various approaches that have been utilized to fabricate stable 
MCs by stabilizing the interparticle interaction at the  liquid-liquid interface. 
 
1.3.1 Factors affecting stability of the colloidal capsules 
“Pickering emulsions” or emulsions stabilized via colloidal particles were 
discovered by S. U. Pickering almost a century ago. It is well-established that 
amphiphilic colloidal particles show a propensity to stay at the interfaces to minimize the 
interfacial energy between immiscible liquids.20  Change in interfacial energy is related 
not only to the effective radius (r) of the particle but also to the surface tension between 
the particle and oil(O) and water (W) by the Pieranski equation as given below.21  
 
ΔE = −πr
2
γo/w
γo/w − (γ p/w −γ p/o )#$ %&
2
 
 
Where γp/o = interfacial energy of particle-oil, γp/w= interfacial energy of particle-water 
and γo/w = interfacial energy of oil-water.  
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The strong particle-size dependence on the energy change in the liquid-liquid 
interface makes it clear that the low energy gain due to small particle size makes the self-
assembly of NPs much more demanding than for larger particles. Thermal fluctuations at 
room temperatures are sufficient to displace the NPs from the interface. As evident from 
the above equation, another factor governing stability of the assembly of NPs is their 
wettability. It is well established that only particles with intermediate wettabilty produce 
kinetically stable emulsions.22 
 
1.3.2 Fabrication of stable capsules from self-assembled nanoparticles at the oil-
water interface 
Interparticle interactions at the liquid-liquid interface are governed by various 
interfacial forces such as capillary forces, solvation forces, electrostatic force, van der 
Waals forces, and fluctuation forces.23 Chemical interactions between the adsorbed 
particles on the interface can be employed as a useful tool to stabilize the colloidal shell 
of MCs. Stronger lateral interparticle interactions will facilitate formation of self-
assembly of NPs at the interface by minimizing the chance for NPs to escape from the 
interface due to thermal fluctuations.  
By crosslinking the NPs assembled at the oil-water interface, significant advances 
have been achieved in the fabrication of stable colloidal MC. Crosslinking the NPs leads 
to the formation of a stable shell at the emulsion interface. This confers the necessary 
mechanical stability to the MCs enabling their isolation and transfer after fabrication. The 
most widely used approach utilizes crosslinking NPs at the oil-water interface via 
chemical bond formations between inter-particle surface ligands. Thus, design and 
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synthesis of novel ligands that afford surface reactive NPs are very important for this 
purpose. In general, crosslinking between NPs at the liquid-liquid interface to yield stable 
microcapsules can be achieved by designing systems that benefit from either covalent 
interaction between NPs and/or non-covalent interactions between NPs. 
Judicious choice of organic ligands on the NP surface provides tools for 
employing different types of covalent crosslinking to obtain NP assemblies with 
improved mechanical properties and structural stability to facilitate handling and transfer. 
Lin et al fabricated stable MCs by crosslinking appropriately modified NPs at room 
temperature using ring opening metathesis polymerization (ROMP).24 CdSe-ZnS quntum 
dots (QDs) coated with a norbornene based ligand were assembled at the oil-water 
interface and those were subsequently crosslinked through a modified 2nd generation 
Grubb’s catalyst in the inner phase of the water-in-oil emulsion (Figure 1.4). Removal of 
the interface by adding methanol to the MCs solution did not disrupt the NPs assembly, 
thus demonstrating the stability of the arrested crosslinked assembly. In a simpler 
approach, Russell and Emrick fabricated MCs using gold NPs coated with a hydroxyl-
terminated amphiphilic ligand. Interfacial crosslinking of the NPs assembled at the 
interface using terephthaloyl chloride led to stable MCs.25 
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Figure 1.4 (a) Norbornene functionalized CdSe QDs and water-soluble Grubb’s catalyst 
(b) Confocal image of the microcapsules stabilized by crosslinking of ROMP. (Adapted 
from ref. 31) 
 
Molecular recognition-based, directed self-assembly of NPs provides a powerful 
tool to fabricate novel functional materials.26 The multivalent nature of interactions 
between the NP building blocks at the interface provides an opportunity to utilize weaker 
non-covalent interactions to obtain stable microcapsules. Furthermore, the reversible 
nature of noncovalent interactions shows potential for the fabrication of dynamic systems. 
Examples from recent literature as outlined below highlight that molecular recognition 
between complementary molecules can be utilized to design NP systems capable of 
benefitting from such stabilizing interactions at the liquid-liquid interface. 
In a recent work, Möhwald et al. utilized hydrogen bonding at the oil-water 
interface to demonstrate stepwise assembly of three different types of NPs having 
different cores and ligands at the liquid-liquid interface to fabricate asymmetric thin 
films.27 Ligands based upon DNA bases such as thymine, adenine and adenosine 3’-
monophosphate were used for the assembly process. As a first step, gold NPs were 
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modified by thymine-functionalized ligands at the toluene-water interface. Second, 
thymine ligand-coated gold NPs were linked with adenine thiol from the oil phase and 
adenosine 3’-monophosphate from the water phases via complementary base pairing 
(Figure 1.5). This surface functionalization strategy using bi-phase allows attachment of 
organo-soluble Ag and water-soluble CdTe NPs onto the gold NPs from their respective 
bulk phases. Thus, asymmetric trilayer thin films of three different NPs were fabricated 
using phase-selective surface-modification of NP surfaces at the oil-water interface.  
 
Figure 1.5 DNA base pairing of NPs that self-assembled at the oil-water interface. 
[Adapted from ref. 33]  
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Fabrication of stable colloidal microcapsules using NPs has been achieved in 
recent years. As demonstrated in the above mentioned examples, fabrication of 
practically useful and functional microcapsules could only be achieved by the 
stabilization of the NP array formed at the liquid-liquid interface, by establishing either 
non-covalent or covalent linkages between the building blocks. Ability to tune the 
interactions between the NPs will also open routes to fabricate stable yet responsive MCs 
that would allow controlled and selective transport of materials in and out of the capsule. 
Such aspects can be tailored into the ligand shell of the NP components using a wide 
variety of available organic reactions, thus enabling design and fabrication of novel NP 
based microcapsules.  
1.4 Non-covalent incorporation of hydrophobic molecules into AuNP monolayers 
Non-covalent incorporation of hydrophobic molecules such as transition metal 
mediated catalysts, cancer drugs, or anti-biotics into AuNP monolayers provides an 
alternative strategy combining the properties of AuNPs and the hydrophobic molecules. 
Hydrophobic molecule encapsulation with AuNPs relies on the use of ligands that 
produce a hydrophobic interior to the monolayer. Structurally, the radial nature of the 
monolayer results in a decrease in ligand density as one goes farther from the core of 
small AuNP cores (< ~6 nm).28 Consequently “hydrophobic pockets” are created inside 
the monolayer of the AuNP into which hydrophobic materials can be partitioned. 
Pasquato et al. demonstrated the encapsulation of radical probes in AuNP monolayers, 
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using EPR spectroscopy to monitor the partition of the lipophilic probe between a 
monolayer of AuNP and bulk water.29 As expected, smaller particles featuring more 
strongly radial monolayers favor guest encapsulation (Figure 1.6). 
 
 
Figure 1.6 (a) Schematic representation of AuNP and  nitroxide probe inclusion. (b) Plot 
of the ratio between the concentration of 2 partitioned in the monolayer and that of the 
free species (! 16 nm;  3.4 nm; " 5.3 nm) as a function of [HS-C8-TEG, 1] bound to 
the gold. 
 
	  14 
The concept of monolayer encapsulation has recently been applied to drug 
delivery. Rotello et al. have developed a biocompatible AuNP carrier that employs 
hydrophobic pockets to first encapsulate drugs and then deliver them into cancer cells.30 
The particles (~ 2.5 nm core) featured a hydrophobic alkanethiol interior and a 
hydrophilic shell composed of a tetra(ethylene glycol) (TEG) unit terminated with a 
zwitterionic headgroup designed to minimize nonspecific binding with 
biomacromolecules31 and other cell surface functionality (Figure 1.7). Hydrophobic 
payloads were kinetically entrapped in the monolayer, with the resulting host-guest 
materials stable in buffer and serum. The entrapped payloads were released into cells by 
membrane-mediated diffusion, as demonstrated both by fluorescence microscopy (using a 
fluorophore payload) and through drug efficacy with therapeutic guests. No particle 
uptake was observed with these systems using ICP-MS, making these systems excellent 
candidates for passive targeting using the enhanced permeability and retention (EPR) 
effect.32 
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Figure 1.7 (a) Structure of particles and guest compounds: Bodipy, TAF, and LAP, the 
number of encapsulated guests per particle (b) Cytotoxicity of AuNPZwit complexes 
measured by Alamar blue assay after 24 h incubation with MCF-7 cells. IC50 of AuNP 
(NP), equivalent drugs (Drug), and free drugs are shown in the table. 
 
1.5 Dissertation overview  
Fabrication of functional structures with intended structures relies on engineering 
the interfaces between nanoparticle building blocks or other building blocks and 
nanoparticles. My research has been oriented toward the fabrication of functional 
structures using various interfaces between nanoparticles and other functional materials 
such as enzymes, catalysts, and polymers. To achieve this, I have employed a synergistic 
approach, combining materials, surface science, organic synthesis, and biology to 
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develop surface-functionalized AuNPs with a tailored monolayer. In the following 
chapters, details of designing functionalized AuNPs and their use as a building block are 
described. 
 
Figure 1.8 Dissertation overview. Schematic illustration of the fabrication of the 
functional structures using AuNPs building blocks described in this thesis. 
 
In Chapter 2, a capsule scaffold for enzyme immobilization will be discussed. 
Emulsions stabilized by enzyme-nanoparticle (NP) complexes were used to fabricate 
robust biocatalytic scaffolds after core solidification. These biocatalysts couple ease of 
formation, high retention of enzymatic activity and reusability. 
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Chapter 3 will discuss the fabrication of nanoparticle monolayer films that have 
tunable elastic modulus. In this chapter, the elastic modulus of an ultrathin NP monolayer 
film is tuned by modulating the binding strength between the NPs at the molecular level. 
NP monolayer films constructed by crosslinking NPs of different binding affinities were 
fabricated at oil/water interfaces. By inducing buckling patterns on these films, the 
correlation between the binding affinity of NPs and the elastic modulus is investigated. 
In chapter 4, the fabrication of nanoparticle dendrimer hybrid capsules for drug 
delivery will be discussed. By transferring a two-dimensional nanoparticle-dendrimer 
composite film to a three-dimensional capsule structure, the resulting materials provide 
controlled drug release, stability, and therapeutic efficacy in vivo. The NDHCs act as a 
drug carrier for cancer therapy in vivo, displaying efficient therapeutic and passive 
targeting ability. 
Chapter 5 will describe the solubilizaton of hydrophobic catalysts through water 
soluble nanoparticle hosts. We report the solubilization of various hydrophobic transition 
metal catalysts achieved by using hydrophobic pockets of water soluble gold 
nanoparticles. Besides preserving original catalyst activity, this nanoparticle platform 
provides a protective environment for the hydrophobic catalyst. Grubbs, Cp*Ru(cod)Cl, 
and Wilkinson catalysts encapsulated in the water soluble AuNPs are used for ring-
opening metathesis polymerization, allyl carbamate cleavage and hydrogenation of 
alkenes, respectively. Recyclability of a nanoparticle-catalyst system is examined for the 
Wilkinson catalyst. This work demonstrates a versatile platform for the encapsulation of 
different hydrophobic catalysts, allowing a wide range of catalysis in water.  
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In Chapter 6, fabrication of allosterically-controlled bioorthogonal catalysis will be 
discussed. Artificial nanozymes that catalyze bioorthogonal reactions broaden the 
functional possibilities of intracellular chemistry.  Effectively delivering and regulating 
the activity of protein-sized, catalytic systems is challenging due to both the complex 
intracellular environment and catalyst instability. We report the fabrication of nanometer-
sized bioorthogonal nanozymes through the encapsulation of hydrophobic transition 
metal catalysts into a monolayer of water-soluble gold nanoparticles. The activity of 
these catalysts could be reversibly controlled by binding a supramolecular cucurbit[7]uril 
‘gate-keeper’ onto the monolayer surface, providing a biomimetic allosteric control 
mechanism. The efficacy of this gated nanozyme was demonstrated by the triggered 
cleavage of an allylcarbamate inside living cells, providing a new type of artificial 
allosteric enzyme for use in imaging and therapeutic applications.  
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CHAPTER 2 
 
 
 
 
REUSABLE BIOCATALYTIC MICROPARTICLES SELF-ASSEMBLED FROM 
ENZYME-NANOPARTICLE COMPLEXES  
 
 
 
2.1 Introduction 
 
Immobilized enzymes provide highly regio- and stereospecific catalysts for 
synthesis,1 pharmaceuticals,2 biosensors,3 and biofuel cells.4  A major goal in designing 
enzyme immobilization strategies is fabricating scaffold structures that overcome 
limitations of free enzymes, such as removal and re-use of the enzyme and lack of long-
term solution5 and interfacial stability.6  
A number of scaffolds have been developed to immobilize and stabilize enzymes, 
including gels,7 macromolecules,8 nanoreactors,9 carbon nanotubes,10 and other surface-
anchored systems.11  Microparticles (MPs) provide particularly attractive scaffolds for 
enzyme immobilization due to their large surface area and ease of separation from the 
reaction mixture by centrifugation, filtration or magnetic methods.12   
Enzymes can be covalently bound to modified particles via various chemistries13 
or adsorbed via hydrophobic, Van der Waals, and electrostatic forces. 14 However, 
biocatalysts generated by these approaches can face challenges including low 
immobilization yield,13 leaching of enzymes from the scaffolds,14 and loss of enzyme 
activity.13,15    
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In recent studies, we successfully immobilized enzyme-NP complexes at oil/water 
interfaces through electrostatic self-assembly.6, 16  While the resulting microcapsules 
effectively retained the activity of the enzyme, re-use of the capsules was prevented by 
the liquid nature of their core. Herein, we report a versatile technique for fabrication of 
crosslinked microparticle scaffolds (CLMP) for enzyme immobilization through 
polymerization of the hydrophobic core of enzyme-NP microcapsules (Figure 2.1). These 
solidified scaffolds retain high enzymatic activity while providing separability using 
magnetic NPs immobilized into the core. This work has been reported as a 
communication in the Chemical Communications.17 
 
 
 
Figure 2.1 Schematic illustrations for the formation of catalytic CLMPs, core 
polymerization using 1st generation Grubbs’ catalyst, and chemical structure of the 
cationic gold nanoparticles used in this study. 
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2.2 Results and discussion  
2.2.1 Formation of enzyme-nanoparticle complexes  
The catalytic CLMPs presented here consist of enzymes, NPs and polymerized 
cores. For our studies we used Candida rugosa lipase, an industrially important 
enzyme. 18   This lipase was selected because its high chemoselectivity, relative 
insensitivity towards non-aqueous solvents, and stability over broad pH and temperature 
ranges.19  In our CLMPs positively charged gold NPs (AuNPs) functionalized with 
trimethylammonium tetra (ethylene glycol) ligands were used to bind to the anionic 
lipase through electrostatic interactions with minimal denaturation.20  The solid core was 
prepared by mixing dicyclopentadiene (DCPD) monomers, 1st generation Grubbs’ 
catalyst, and 1,2,4-trichlorobenzene (TCB) to adjust the buoyancy and control the rate of 
polymerization.  
To effectively stabilize the microcapsules, the charge density of enzyme-NP 
complexes was optimized by the molar ratio of NP to enzyme. Since the high surface 
energy associated with the emulsions requires materials with a low charge density for 
stabilization,21 zeta potential values of enzyme-NP complexes in terms of the molar ratio 
were measured to fabricate the complexes with the lowest charge (Figure 2.2a). The 
complexes made using a 2:1 NP to enzyme ratio resulted in essentially neutral particles 
with a -0.213 mV zeta potential value. This 2:1 NP to enzyme ratio was used for all 
subsequent experiments.  
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Figure 2.2 (a) Zeta potential values of enzyme-NP complexes fabricated at varied molar 
ratios of NP to lipase, (b) Optical image of CLMPs. 
 
After formation of the MCs by homogenization and polymerization of the core 
upon standing (2 h), the CLMP biocatalysts were found be spherical with diameters of 20 
± 7 µm (Figure 2.2b). IR spectroscopy was used to confirm the polymerization of the 
core scaffold, indicated by the increased absorption intensities at 1665 cm-1 and 965 cm-1 
characteristic of the ring-opened product of poly(DCPD) (Figure 2.3).22 
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Figure 2.3 IR spectrum of the CLMPs, DCPD and lipase 
 
2.2.2 Fabrication of crosslinked microparticle scaffolds  
The efficiency of a biocatalyst is determined by accessiblity of substrates, enzyme 
immobilization yield, retained activity and reusability. FITC-labeled lipase was used for 
the fabrication of CLMPs to demonstrate the successful immobilization of lipases on the 
CLMP surface. A distinct green fluorescence was observed on the entire surface of 
CLMPs under 494-nm excitation, proving the presence of lipases (Figure 2.4a). To 
further study the structure of CLMPs, FITC-labeled lipases and an oil phase containing 
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1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate (DiI) were used for 
investigation with confocal microscopy. As shown Figure 2.4b, FITC-labeled lipases 
were selectively located on the surface and the red fluorescence of the DiI was observed 
in the core. These results indicated selective enzyme-immobilization at the surface of 
CLMPs, providing accessibility for reactants. 
 
Figure 2.4 (a) A fluorescence microscope image of catalytic CLMPs fabricated using 
AuNPs and fluorescein-labeled lipase in a buffer solution (b) a confocal image of a FITC-
labeled lipase immobilized CLMP including DiI in the core (488 nm and 543 nm 
excitation) c) Formation of catalytic CLMPs incorporating Nile red and magnetic NPs in 
the core. 
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2.2.3 Crosslinked microparticle scaffolds as a biocatalyst 
The quantity of lipase immobilized onto the CLMPs was calculated by measuring 
the amount of residual free enzymes in the water phase using a Bradford protein assay. 
Less than 5% of the enzymes remained in the water phase of CLMPs, indicating that >95% 
of the enzyme was successfully immobilized on the polymerized scaffolds (Figure 2.5a).  
The enzymatic activity of the CLMPs was determined through fluorometric 
enzyme activity assays using 8-octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt 
(OPTS) substrates in an aqueous solution.23  Significantly, the activity of catalytic 
CLMPs was almost 3-fold higher than that of free lipase, with no detectable auto 
hydrolysis observed (Fig. 3b). This enhancement in activity presumably arises from the 
hydrophobic environment of the scaffold, as prior studies have observed increases in 
activity in hydrophobic environments. 24 In addition, the calculated ionic strength of 0.2 
M OPTS solutions is 1.2 M, indicating that the CLMPs retain enzymatic activity in high 
ionic strength environments. 
A useful feature of the structure of CLMPs is that the system can be readily 
equipped with magnetic properties through the simple addition of magnetic NPs into the 
oil phase. To demonstrate this versatile feature, Nile red and oleic acid-functionalized 
magnetic nanoparticles (10 nm core diameter Fe2O3 NPs25) were added into the oil 
mixture. After the fabrication of the CLMPs using this oil phase, the MPs can be 
efficiently collected using a magnet (Figure 2.4c). 
Reusability of the enzymes on the CLMPs was investigated through repeated 
enzymatic activity assays. The CLMPs and enzyme-immobilized microcapsules were 
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placed in a 0.2 µm pore membrane bags for easy separation from the reaction mixture and 
to prevent loss during the washing process.26 As shown in Figure 2.5b, the CLMPs 
exhibited essentially identical activity after repeated uses, while enzyme-immobilized 
microcapsules with liquid cores lost 80% of their initial activity after 2 cycles of use. In 
addition to reusability, the CLMPs provided exceptional long-term stability. In aqueous 
solution, the CLMPs retained complete enzymatic activity over 10 days while the free 
lipase lost almost of all of their activity at room temperature in 3 days (Figure 2.5d). 
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Figure 2.5 (a) The percentage of free lipase remaining in the water phase after the 
CLMPs construction (b) activity assays of lipases of the CLMPs and free lipase in 
phosphate buffer (5 mM) and inset shows the relative activity (free enzyme solution = 
100%) (c) the relative activity of the catalytic CLMPs before and after core-solidification 
with recycled use (d) relative activity of the CLMPs and free lipase in terms of time 
 
 
2.2.4 Crosslinked microparticle scaffolds in organic solvent  
To ascertain the utility of the catalytic scaffold for use in organic solvents, the 
core stability of the CLMPs was investigated.  When acetone was added to the solutions 
of enzyme-immobilized microcapsules, the CLMPs kept their original shape while the 
microcapsules with unpolymerized core were observed to increase in size and undergo 
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deformation in shape (Figure 2.6 a,b). An enzyme activity assay was performed in a 
mixture of acetone and water (1:1). The CLMPs were shown to retain enzymatic activity 
(Figure 2.6c). 
 
Figure 2.6 Optical images of (a) enzyme-immobilized CLMPs (b) CLMPs in acetone (c) 
activity assay of enzyme-immobilized CLMPs and free enzyme in a mixture of acetone 
and water (1:1) 
 
 
2.3 Summary and future outlook  
In summary, we have developed a new strategy for the creation of supported 
biocatalysts through core polymerization of nanoparticle-stabilized microcapsules. The 
resulting materials provide stabilization of the enzyme, ease of removal of the catalyst, 
and increased tolerance of non-aqueous solvents. The versatility of these microparticles 
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can be further enhanced through incorporation of materials into their core, providing an 
effective scaffold for biocatalysis.  
In this study, we found out the immobilized enzymes can preserve their activity in 
harsh condition such as organic solvent or high ionic strength. Based on this result, we 
can assume that the immobilized enzyme can preserve their original structures at the 
harsh condition since the polymer matrix presumably holds their structures. Therefore, 
the immobilized enzymes can be used at high temperature with high activity, overcoming 
the limitation of enzymes.  
 
2.4 Synthesis of materials and experimental methods  
Lipase (candida rugosa lipase), dicyclopentadiene (DCPD), ruthenium-based 1st 
generation Grubbs’ catalyst and 1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine 
perchlorate were purchased from Sigma-Aldrich. Trichlorobenzene (TCB) was purchased 
from Fluka Chemicals. Compat-Able Protein Assay Kits and Coomassie blue (Bradford 
protein assay kit) were purchased from Thermo Fisher Scientific Inc. 8-
Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt (OPTS) was purchased from 
Markergene Technology Inc.  
Zeta potential values were measured using a MALVERN Zetasizer Nano ZS 
instrument. Each sample was scanned three times and an average value was reported. 
Optical and fluorescence microscopy images were taken using an Olympus IX51 
instrument and enzymatic activity assays were performed by plate fluorescence reader 
(SpectraMax M5). Confocal pictures were obtained on a Zeiss LSM 510 Meta 
microscope using 63X objective. 
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2.4.1 Synthesis of ligand and fabrication of nanoparticle  
Positively charged gold nanoparticles (AuNPs) were synthesized according to 
previous reports.27 In brief, pentanethiol-coated AuNPs with a core diameter of 2 nm 
were synthesized using the Brust-Schiffrin two-phase method. 28  A Murray place-
exchange reaction was used to obtain the quaternary ammonium functionalized AuNPs.29 
Oleic acid coated iron oxide nanoparticles with a core diameter of 10 nm were 
synthesized through the thermal decomposition of Fe(CO)5 in organic solvents and 
subsequent oxidation in air.25 
 
2.4.2 Experimental methods  
2.4.2.1 Enzyme-immobilized microparticle (CLMP) preparation 
0.72 µM of AuNPs functionalized with trimethylammonium tetraethylene glycol 
ligands were mixed with 0.36 µM of lipase in 200 µL of 5 mM phosphate buffer (pH 7.4). 
The oil phase was prepared through mixing 90 µL DCPD, 8 µL TCB and 2 µL of 5% 
Grubbs’ catalyst in toluene. Immediately after preparing the oil phase, 5 µL of the oil 
phase was added to the mixture of lipase and AuNPs. After adding the oil phase, the 
solution was mechanically agitated via amalgamator. After 2 h, enzyme-immobilzed MPs 
were purified using a membrane bag. 
2.4.2.2 Enzyme immobilization yield (enzyme quantification method):  
The immobilization yield of the lipases was calculated by measuring the amount 
of residual enzymes in the solution of MPs using a Bradford protein assay. Free 
nanoparticles and any interfering substances were first removed using Compat-Able 
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Protein Assay Kit and the calibration with a standard sample was carried out.  
2.4.2.3 Enzyme activity assay 
Enzyme activity assays in a 5 mM buffer solution were performed using OPTS as 
a substrate and fluorescence of products were analyzed over time using plate fluorescence 
reader (λex/λem: 460/510 nm). The molarity of the OPTS was 0.2 M and calculated ionic 
strength was 1.2 M, which is 6-fold higher than that of 100 mM phosphate buffer. 4-
nitrophenyl acetate was used as the substrate for enzyme activity assays in the mixture of 
acetone and water and the absorbance of products was observed at 450 nm. Washing 
processes were performed before the repeated reuse of biocatalysts as shown in Figure 
2.7 The MPs and enzyme-immobilized MCs in 100 µL water phase were washed by 4 L 
of water for 4 hour using 0.2 µm pore-sized membrane bag. 
 
 
Figure 2.7 (a) Schematic illustration of the repeated washing processes and enzyme 
activity assays of MPs for recycling test (b) picture of 0.2 µm pore size membrane bag 
including the MPs 
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CHAPTER 3 
 
 
 
 
TUNABLE ELASTIC MODULUS OF NANOPARTICLE MONOLAYER FILMS 
BY HOST-GUEST CHEMISTRY  
 
3.1 Introduction 
Thin films containing inorganic nanoparticles (NP) have attracted widespread 
attention due to their applications in functional devices that benefit from the characteristic 
optical,1 magnetic,2 or electronic,3 properties of the incorporated NP.4 Furthermore, the 
solid core of inorganic NPs provides a platform for the engineering of mechanical 
properties.5 The pliability of soft materials has been integrated through the creation of NP 
composite materials with support materials such as polymers, 3b,4b proteins,6 and other 
materials. 2,7 In these NP composite materials, the mechanical properties can be tuned by 
controlling the NP composition. However, the fabrication of ultrathin NP composite 
materials with homogeneous mechanical properties is a challenge since the unintended 
aggregation of NPs in the soft materials generates defect sites that have less NP 
composition.8 
Recently, there have been a few reports on the manufacture of robust free-
standing ultrathin films and membranes without defect sites from NPs alone.9 These 
fabrication processes generally rely on supramolecular self-assembly of NPs through 
designed interactions between the outer ligand shells of individual NPs. For example, 
Schmid et al. reported a method that fabricate ordered two-dimensional NP monolayer 
film on polymer film. 9c In spite of the ultrathin nature of the NP films, the multiple non-
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covalent interactions between the NPs can provide useful mechanical properties. To 
investigate the mechanical properties at the thickness limit of the NP films, monolayer 
and multilayer films of NPs have been studied. Mueggenburg et al. determined that the 
elastic modulus of a gold NP array was related to the structural arrangement of the NPs 
within the film.10 Lee et al. investigated the viscoplastic behavior of CdSe NP films 
hundreds of particles thick.11 To date, the design of ultrathin NP films allowing their 
mechanical properties to be adjusted in a controlled fashion has not yet been investigated.  
 
3.1.1 Controlling the mechanical properties of nanoparticle composite films 
Modulation of the supramolecular interactions between NPs in the NP films can 
allow tuning of the bulk mechanical properties. Supramolecular assemblies including 
those based on electrostatic interactions, hydrogen-bonding, and hydrophobic forces have 
been harnessed to dictate the properties of self-assembled structures by means of 
modulated non-covalent interactions.12 Particularly useful are the engineered interactions 
provided by the designed building blocks developed in the field of host-guest chemistry.  
Our hypothesis was that the tunability of host-guest processes could be used to 
dictate the mechanical properties of ultrathin particle sheets. Multivalent interactions 
between NP would modulate the strength of the inter-NP interactions, in turn defining the 
mechanical properties of the macroscopic self-assembled NP film. Here, we present the 
fabrication NP monolayer films at the oil/water interface that are laterally crosslinked 
using specific host-guest chemistry, thereby tailoring the binding affinities between NPs 
Different divalent molecular linkers were designed to complex with cyclodextrin-
decorated NPs to form NP films with varying interparticle interaction strengths. Buckling 
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wavelength was then used to demonstrate control of the thin film modulus, with the 
affinity of the host-guest interactions directly correlated to binding affinity of the 
recognition elements.  (Figure 3.1). This work has been reported as a communication in 
the Advanced Materials.13 
 
Figure 3.1 Structure of (a) 2-nm β-CD NPs and (b) cross-linker molecules with various 
binding affinities to the β-CD-NPs. (c) Scheme for the film formation at the oil/water 
interface. (d) After formation of the NP film, the internal liquid phase (dicyclopentadiene 
(DCPD) and Grubbs’ catalyst) was polymerized, which reduced the internal volume and 
generated buckling patterns of the NP films crosslinked by the designed linkers on the 
surface of the particle. 
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3.1.2 Buckling-based metrology for measuring elastic modulus 
Given the fragility of monolayer NP films we used buckling as a probe for 
mechanical properties. Buckling-based metrology is an effective method for the 
determination of elastic moduli of thin films.14 In brief, the thin film of interest is 
transferred to a relatively thick flat template and subjected to an applied compressional 
strain that leads to buckling instability. Depending on the properties of the thin film and 
substrate, unique buckling patterns are generated that minimize the overall energy in the 
system. By assuming a sinusoidal waveform of the generated buckling instability, the 
wavelength of buckling (d) can be expressed by Equation 114: 
         or                  (1) 
where h is the film thickness, Ē = E/(1-ν2), E is the elastic modulus, ν is the Poisson’s 
ratio, and the subscripts f and s represent film and substrate, respectively. The modulus 
mismatch is estimated by buckling wavelength and the thickness of the film. 14,15 This 
method has been used previously to describe NP film formed at the air/water flat 
interface. However, since the measurement of the binding affinity between the NPs and 
linkers at the flat interface is challenging due to the small interfacial area, the NP 
monolayer films discussed here are formed at a spherical interface of oil/water emulsion 
to increase surface area. To estimate the modulus mismatch of the NP film, Cao’s 
spherical model16 that defines the relationship between the buckling wavelength and the 
radius of the sphere substrate was adapted. The relationship can be expressed as in 
Equation 2:  
d = 2πh Ef3Es
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           (2) 
where a and b are fitting parameters and R is the radius of the sphere. Cao et al. 
demonstrated the effect of the curvature of the film (R/h) on the normalized buckling 
wavelength (d/R) of the thin films through numerical simulations and experimental 
observation. 16a According to Cao’s work and other subsequent studies, 16 the values of a 
and b are associated with the elastic modulus mismatch between the film and the 
substrate, and the geometry, respectively. 16a We constructed NP films by cross-linking 
NPs of different binding affinities on spherical substrates of various diameters. From 
their buckling patterns and curvatures, the coefficients a of each of the NP films were 
gained. By tracing the coefficient a of the films and the binding affinity between the NPs, 
we find the binding affinity effectively influences the elastic modulus of the NP films. 
 
 
3.2 Results and discussion  
3.2.1 Nanoparticle monolayer film on the spherical emulsions  
To fabricate the films on spherical substrates, NP films were formed at the 
oil/water interface of emulsions. When the oil droplets containing the linker molecules 
were added to an aqueous NP solution, the NPs self-assembled at the oil/water interface 
to minimize the surface energy. The linkers present in the oil phase cross-linked the β-CD 
NPs, causing a NP membrane shell to form (Figure 3.1c). By shrinking and solidifying 
the inner phase of the emulsion via polymerization, we were able to obtain buckling 
patterns of the NP films on a spherical substrate,17  (Figure 3.1d) and thus deduce the 
elastic modulus of the NP films based on Equation (2). To confirm the formation of the 
d
R = a
R
h
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NP film at the oil/water interface of the spherical emulsions, a Pickering emulsion18 was 
produced using oil (chloroform) containing the linker (AB-Hex-AB) and β-CD NPs as 
described in Figure 3.1c. The assembled NPs at the interface were cross-linked by their 
linkers to form microcapsules. Microcapsules were analyzed by using optical and 
transmission electron microscopy (TEM). The optical microscope images showed sphere-
shaped microcapsules (Figure 3.2a) and crumpled NP films after drying of the oil phase 
(Figure 3.2b). These results indicate that the β-CD NPs were cross-linked by the AB-
Hex-AB moiety, forming NP films. To confirm the film formation by the host-guest 
complexation in the microcapsule, we combined the α-CD NPs with AB-Hex-AD linkers 
as a control experiment. While Pickering emulsions did form at the interface, the α-CD 
NPs were redispersed in the water after drying of the oil phase as AB-Hex-ADs cannot 
cross-link the NPs to create a film. Since the AD moiety of the linker is sterically too 
large to fit into the α-CD cavity,19 inclusion complexes of the NPs at the interface did not 
form and film formation did not occur. In the TEM images (Figure 3.2c, d), while the 
microcapsules made of α-CD NP showed only aggregated NPs or single NPs upon drying, 
the microcapsule constructed from β-CD NPs displayed a circular-shaped crumpled film 
in the TEM images (Figure 3.2c, d). 
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Figure 3.2 The formation of the membrane made of cross-linked NPs Microscope image 
of the microcapsules made of β-CD NPs and the linker (AB-Hex-AB) (a) before and (b) 
after drying of the inner phase (chloroform). Inset of (b) shows the formation of the 
membrane (inset of b). (c) TEM image of the crumpled membrane made of β-CD NPs 
and the AB-Hex-AB linker (d) TEM image showed only single NPs or randomly 
aggregated NPs when the Pickering emulsions were made of α-CD NPs and oil including 
the linker (AB-Hex-AD), indicating the absence of cross-linking by the linker. 
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3.2.2 Buckling patterns of nanoparticle monolayer film crosslinked by different 
binding affinities  
We designed three linkers with different binding affinities to the β-CD NPs 
(Figure 1a,b) to provide tunable modulation of binding affinities between the β-CD NPs. 
In previous reports, adamantane moieties have been shown to have higher binding 
affinities20 (ca. 52000 M-1) than benzyl groups21 (ca. 800 M-1) for β-CD. Therefore, we 
hypothesize that, of our linkers, the binding affinities for the NPs would be in the order of 
AD-Hex-AD>AB-Hex-AD>AB-Hex-AB. In our system, the binding environment is 
complicated as the linkers have two binding sites, while the NP have many β-CD 
moieties in their ligand layer, and can only interact at the oil/water interface. To probe 
binding events, we directly measured the affinities between the β-CD NPs and the linkers 
at the interface using isothermal titration calorimetry (ITC). In this experiment, a dilute 
emulsion of oil droplets containing the linker molecule was titrated against β-CD NPs.22 
The total heat change indicates the sum of heat change from the NP interactions between 
the oil droplets and the linker moieties. To subtract the contribution from the heat change 
from the interaction between the oil and the NPs, a titration was also conducted with 
droplets devoid of any linker molecules. The results shown in Table 3.1 confirmed that 
the binding affinities between the NPs and the linker have the same trend as that of their 
small-molecule counterparts; AD-Hex-AD>AB-Hex-AD>AB-Hex-AB in terms of 
binding affinity to β-CD NPs at the interface, (Table 3.1, and Figure 3.3) 
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Table 3.1 Thermodynamic parameters of the β-CD NPs and the linkers at the interface, 
as found by ITC. 
Linker ΔH (cal mol-1) 
ΔS* 
(cal mol-1) 
ΔG* 
(cal mol-1) 
K 
(M-1) 
AB-Hex-AB 3.30 ± 0.05 × 108 1.09 × 106 -9.01 × 103 3.21 ± 0.08 × 106 
AB-Hex-AD 7.2 ± 0.2 × 107 2.39 × 105 -9.26 × 103 4.8 ± 0.2 × 106 
AD-Hex-AD 3.62 ± 0.04 × 108 1.19 × 106 -9.41 × 103 6.2 ± 0.1 × 106 
*The entropy change (ΔS) and the change of Gibb’s free energy (ΔG) were obtained 
through calculation. K is the binding affinity of the linker to the β-CD NP on the 
oil/water interface. 
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Figure 3.3 ITC spectra of three droplet including the linkers titrated with β-CD 
functionalized NPs. (The value of N is fixed to 1.50 × 10-4 obtained from the blank 
experiment. We assumed that the same numbers of NPs were localized at the interface of 
the naked droplets and the same numbers of linkers bound to a β-CD-functionalized NP.) 
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The inner phase of the capsule was replaced with a mixture of dicyclopentadiene 
(DCPD), Grubbs’ catalyst, and the linker solution (5 µM AB-Hex-AB, AB-Hex-AD, or 
AD-Hex-AD in chloroform; Figure 3.1c to create measurable buckling patterns for 
wavelength determination.23 After the formation of the NP films at the interface of the 
emulsion, the DCPD layer was polymerized to convert the capsules into stable 
microparticles with buckled surfaces (Figure 3.4). Buckling of the microparticles’ surface 
occurs due to the shrinkage of the inner phase, which is caused mainly by the removal of 
the chloroform and the decreased volume of the polymer relative to its constituent 
monomers. The buckling stress and hence the applied stress can be altered by adjusting 
the volume content of chloroform. As expected, we observed the buckling morphology 
depended on the amount of chloroform. Periodic buckling patterns were obtained when 
the volume fraction of the chloroform was 1% (Figure 3.5). When the volume content of 
the chloroform was increased to 10%, the NP films showed a crumpled structure 
consistent with the application of large strains (Figure 3.6). This crumpled structure may 
relate to the previous reported strain localization events.24 
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Figure 3.4. SEM images of the microparticles composed of different linkers with the 
buckling patterns. 
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Figure 3.5 SEM images of the buckling patterns on the microparticles. The buckling 
patterns of the NP films crosslinked by AB-Hex-AB (a, d), AB-Hex-AD (b,c), and AD-
Hex-AD (c, f) obtained by polymerizing the inner phase of the microcapsules. 
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Figure 3.6 SEM images of microparticles composed of different linkers showing their 
crumpled structures. 
 
 
We analyzed the periodic buckling morphology induced with the volume content 
of chloroform of 1% since it provided a more homogeneous surface structure. Moreover, 
different linkers produced different characteristic lengths of periodic buckling under this 
stress condition. This result is consistent with the hypothesis that the elastic properties of 
the cross-linked NP films vary depending on the chosen linker. To probe the buckling 
phenomenon further, microparticles composed of α-CD NPs and AB-Hex-AD or AD-
Hex-AD linkers were also investigated, which contained the NPs and linkers but did not 
form the film (Figure 3.7). These microparticles were unable to keep their spherical shape 
during the polymerization and no buckling patterns observed in their surface. From this 
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control experiment, we can assume that the buckling phenomenon of the microparticle 
surface is related only to the laterally supramolecularly crosslinked NP film formed 
through the inclusion complexation between the NPs and linkers. 
 
 
 
Figure 3.7 SEM images of microparticles composed of the α-CD-functionalized NPs and 
inner-phase including the linkers. 
 
 
3.2.3 The correlation between elastic modulus of nanoparticle monolayer film and 
binding affinities between nanoparticles  
From the SEM images of the buckling patterns, we observed that microparticles 
fabricated from the same linker have different buckling wavelengths depending on their 
radius. The observation is in agreement with Cao’s simulation study using the finite-
element method. We also found that the small microparticles do not experience sufficient 
stress to form buckling structures, which is consistent with previous results of wrinkling 
on a spherical substrate, and is related to the influence of curvature on the critical 
buckling stress.25 From the SEM images of the microparticles, the wavelengths (d) were 
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characterized in terms of the radius (R) of the microparticle. The thickness (h) of the NP 
film was assumed to be 10 nm, which is the diameter of the β-CD NPs as obtained using 
dynamic light scattering and estimated from the SEM image of a cracked surface of the 
NP monolayer (Figure 3.8 and 3.9). The calculated values of d/R were assigned in terms 
of the value R/h in Table 3.3-3.5. These data were fitted in two different ways. First, the 
data were fitted with a power law with a fitting exponent b, which is found in reasonable 
agreement with that predicted by Cao’s calculation (Figure 3.10 a-c; Table 3.2). We also 
fit the data to Equation (2) using b from Cao’s simulated value (b=-0.8) [15c,16a] to 
compare the value of the coefficient a and estimate the elastic modulus of each film 
(Figure 3.10d). This coefficient value reflects the ratio between the elastic moduli of the 
soft substrate and the stiff film. 16a,c As the same soft substrate (poly-DCPD) is used, each 
value of a directly reflects the elastic modulus of each film. Notably, the trend in the 
coefficient a for each film agrees with the order of the binding constants between the NPs 
and linkers found earlier. This result shows the moduli of our films are successfully 
controlled by binding affinities between the NPs and linkers.  
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Figure 3.8 TEM image and the DLS result for β-CD-functionalized NPs. 
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Figure 3.9 SEM images of microparticles composed of the β-CD-functionalized NPs and 
inner phase including the linkers. The unbuckled (a,b) and buckled (c,d) surfaces of the 
microparticles are covered by closed-packed NPs (ca. 10 nm). From the image of the 
cracked surface of microparticle, it is confirmed that the NPs film was fabricated as NP 
monolayer (white arrows indicate the single NPs) 
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Table 3.2 The values of fitting parameter a for each linker molecule 
Linker a b a* 
AB-Hex-AB 
(K= 3.21 ± 0.08 × 106) 0.290 ± 0.0001 -0.790 ± 0.0001 0.40 ± 0.04 
AB-Hex-AD 
(K=4.8 ± 0.2 × 106) 1.998 ± 0.0001 -0.824 ± 0.0009 1.95 ± 0.09 
AD-Hex-AD 
(K=6.2 ± 0.1 × 106) 6.800 ± 0.0001 -0.822 ± 0.002 6.27 ± 0.25 
* These values were gained by using a fixed exponent (Cao’s model: b=-0.8). 
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Figure 3.10 Normalized buckling wavelength (d/R) as a function of R/h. The normalized 
buckling wavelengths of the NP films cross-linked by AB-Hex-AB (a), AB-Hex-AD (b), 
and AD-Hex-AD (c) were plotted in terms of normalized radius of microparticles. (d) 
The fitting plots of the normalized buckling wavelengths of the NP films in log scale for 
comparing each coefficient a and exponent b. Markers and lines present the experimental 
values and theoretical values from Cao’s simulations, respectively. 
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3.3 Summary and future outlook  
In summary, we have demonstrated that the mechanical properties of ultrathin 
monolayer NP films can be tuned by altering the binding affinities between NPs using 
specific supramolecular interactions. The durability of the NP films can be tailored for a 
particular application by adding designed linkers. More specifically, a wide range of 
functional groups can be incorporated to our linkers, creating a library of linkers with 
different binding affinities. By simply adding the linkers with higher binding affinities, in 
situ control of the elastic modulus of NP films could be achieved, providing a general 
strategy for constructing ultrathin NP composites with finely tunable mechanical 
properties. These tunable surfaces have potential for the generation of new surfaces for 
materials and biological interfaces.26  
To clarify the relationship between the fitting parameter a and the elastic modulus 
of NP monolayer film, simulation studies using the various elastic moduli and curvatures 
of the substrates might need. After this simulation study, the exact meaning of parameter 
a can be explained. Therefore, the precise relationship between the binding affinities and 
the elastic modulus can be defined.    
 
3.4 Synthesis of materials and experimental methods  
3.4.1 Synthesis of ligand and fabrication of nanoparticle   
3.4.1.1 Synthesis of CD-functionalized NP and linkers 
Perthio α-/β-CD (SH- α-/β-CD) was synthesized according to reported 
procedures.27 In brief, α-/β-CD-coated gold NPs (α-/β-CD NPs) were produced in the 
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presence of SH- α-/β-CDs by the reduction of tetrachloroauric acid (HAuCl4) with 
NaBH4.28 
3.4.1.2 Synthesis of 4-Phenylazobenzoylfluoride  
A suspension of 4-phenylazobenzoic acid (0.226 g, 1 mmol) and pyridine (0.162 
mL, 2 mmol) in dry CH2Cl2 (5 mL) was cooled to 0°C under an argon atmosphere. To 
this solution was added cyanuric fluoride (0.172 mL, 2 mmol), and the contents were 
stirred for 90 min. A deep red/orange color was observed. Crushed ice/water (5 g) was 
then added, the suspension filtered, and the organic layer separated and washed with cold 
water (2 x 5 mL). Concentration in vacuo provided orange crystalline powder that was 
used in the next step without any further purification. 
 
 
 
Figure 3.11 Synthesis of 4-phenylazobenzoylfluoride. 
 
3.4.1.3 Synthesis of Adamantoyl-Hexanol (AD-Hex-ol) 
The solution of Adamantane-1-carbonyl chloride (1.0 g, 5 mmol) and 
triethlyamine (TEA, 1.012 g, 10 mmol) in dry 30 mL of dry CH2Cl2 was added to the 
suspension of 1,6-hexanediol (2.954 g, 25 mmol) and dimethylaminopyridine (DMAP, 
0.305 g, 2,5 mmol) in 30 mL dry CH2Cl2. The mixture was allowed to react for 48 h at 
room temperature. The reaction mixture was extracted with 1M HCl (2 x 30 mL) and 
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then H2O (3 x 30 mL). The organic phase was dried over anhydrous Na2SO4, filtered and 
the volatiles were then evaporated under vacuum. The crude product was purified by 
column chromatography with ethyl acetate:hexane (10:90) to yield adamantoyl-Hexanol 
(AD-Hex-ol). 1H NMR spectrum (CDCl3, δ, ppm) = 4.02 (t, 2H), 3.65-3.60 (q, 2H), 1.99 
(m, 3H), 1.86-1.85 (d, 6H), 1.69 (t, 6H), 1.61-1.56 (m, 4H), 1.38-1.35 (p, 4H). 
 
Figure 3.12 Synthesis of adamantoyl-hexanol (AD-Hex-ol). 
 
 
3.4.1.4 Synthesis of 1-Adamantoyl-6-(4-phenyl)azobenzoyl-hexane (AB-Hex-AD) 
The solution of 4-phenylazobenzoylfluoride (55 mg, 0.225 mmol) in 3 mL dry 
CH2Cl2 was added to the suspension of 6-Adamantoyl-hexanol (56.5 mg, 0.2 mmol) and 
DMAP (24.7 mg, 0.2 mmol) in 2 mL dry CH2Cl2. The mixture is stirred for 24 h. at room 
temperature. After stirring, it was extracted with H2O (2 x 10 mL) and CH2Cl2 (2 x 20 
mL). The organic phase was dried over anhydrous Na2SO4, filtered and the volatiles were 
evaporated under vacuum. The crude product was purified by column chromatography 
with ethyl acetate:hexane (10:90) to yield an orange solid product. 1H-NMR (CDCl3, δ, 
ppm) = 8.18-8.16 (d, 2H), 7.95-7.92 (d, 2H), 7.53-7.51 (d, 2H), 4.34 (t, 2H), 4.05 (t, 2H), 
1.98 (m, 3H), 1.86 (d, 6H), 1.83-1.77 (p, 2H), 1.69 (m, 6H), 1.65-1.62 (p, 2H), 1.51-1.41 
(m, 4H).13C NMR (CDCl3, δ, ppm): 178.0, 166.3, 155.4, 152.8, 132.4, 131.9, 130.8, 
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129.4, 123.4, 122.8, 65.4, 64.2, 41.0, 39.1, 36.8, 28.9, 28.8, 28.2, 26.0, 25.9, 25.8. MS 
(FAB): m/z calculated for [M+H]+: 489.2755; found: 489.2734. 
 
Figure 3.13 Synthesis of the linker AB-Hex-AD. 
 
3.4.1.5 Synthesis of 1,6-di(4-(phenyldiazenyl)benzoyl)-hexane (AB-Hex-AB) 
The solution of 4-phenylazobenzoylfluoride (367 mg, 1.50 mmol) in 6 mL dry 
CH2Cl2 was added to the suspension of 1,6-hexanediol (53 mg, 0.45 mmol) and DMAP 
(73 mg, 0.6 mmol) in 4 mL dry CH2Cl2. The mixture is stirred for 24 h. at room 
temperature. After stirring, it was extracted with H2O (2 x 10 mL) and CH2Cl2 (2 x 20 
mL). The organic phase was dried over anhydrous Na2SO4, filtered and the volatiles were 
evaporated under vacuum. The crude product was purified by column chromatography 
with ethyl acetate:hexane (3:97) to yield an orange solid product. 1H-NMR (CDCl3, δ, 
ppm): 8.13-8.11 (d, 4H), 7.88-7.86 (d, 8H), 7.47-7.45 (d, 6H), 4.32 (t, 4H), 1.79 (t, 4H), 
1.51 (t, 4H). 13C NMR (CDCl3, δ, ppm): 166.3, 155.4, 152.8, 132.3, 131.9, 130.8, 129.4, 
123.4, 122.8, 65.4, 28.9, 26.1. Anal. Calculated for C32H30N4O4: C 70.456, H 5.767, N 
10.270, O 13.508. Found: C 70.218, H 5.989, N:10.615, O 13.176. 
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Figure 3.14 Synthesis of the linker AB-Hex-AB. 
 
 
3.4.1.6 Synthesis of Adamantane-1-carbonylfluoride 
A suspension of adamantane-1-carboxylic acid (0.5 g, 2.7 mmol) and pyridine 
(0.437 mL, 5.4 mmol) in dry CH2Cl2 (13.5 mL) was cooled to 0°C under an argon 
atmosphere. To this was added cyanuric fluoride (0.464 mL, 5.4 mmol), and the contents 
were stirred for 90 min. A deep red/orange color was observed. Crushed ice/water (13.5 
g) was then added, the suspension filtered, and the organic layer separated and washed 
with cold water (13.5 x 2 mL). Concentration in vacuo provided white crystalline powder 
that was used in the next step without any further purification. 
 
 
Figure 3.15 Synthesis of adamantane-1-carbonylfluoride. 
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3.4.1.7 Synthesis of 1,6-diadamantoylhexane (AD-Hex-AD) 
The solution of adamantane-1-carbonylfluoride (99 mg, 0.5 mmol) in 6 mL dry 
CH2Cl2 was added to the suspension of adamantoylhexanol (112 mg, 0.4 mmol) and 
DMAP (49 mg, 0.4 mmol) in 4 mL dry CH2Cl2. The mixture is stirred for 24 h. at room 
temperature. After stirring, it was extracted with H2O (2 x 10 mL) and CH2Cl2 (2 x 20 
mL). The organic phase was dried over anhydrous Na2SO4, filtered and the volatiles were 
evaporated under vacuum. The crude product was purified by column chromatography 
with hexane to yield a white solid product. 1H-NMR (CDCl3, δ, ppm) = 4.02 (t, 4H), 1.99 
(m, 6H), 1.86 (d, 12H), 1.69 (t, 12H), 1.61 (p, 4H), 1.36 (p, 4H). 13C NMR (CDCl3, δ, 
ppm): 178.0, 64.2, 41.0, 39.1, 36.8, 28.8, 28.2, 25.8. MS (FAB): m/z calculated for 
[M+H]+: 443.3163; found: 443.3146. 
 
 
Figure 3.16 Synthesis of the linker AD-Hex-AD. 
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3.4.2 Experimental methods  
3.4.2.1 Preparation of the microcapsules for optical microscopy 
To fabricate the microcapsules, α-/β-CD NP solutions (10 µM β-CD NPs in H2O) 
and oil including the linkers (5 µM linkers in chloroform) were prepared. To 1.5 mL of 
the NP solution, 100 µL of the linker/oil solution were added and rapidly agitated. 
Microcapsules were produced and precipitated due to the density of the chloroform. To 
wash out the excess NPs, 1 mL of solution was decanted and the same amount of milli-Q 
water was added. This washing process was repeated 3-4 times. The microcapsules were 
characterized by using optical microscopy (Olympus IX-51) and TEM (JEOL CX-100).  
3.4.2.2 ITC measurement 
Isothermal titration calorimeter (ITC) experiments were performed at 30°C using 
a MicroCal VP-ITC instrument. Oil droplets (5 µM linkers in chloroform) were generated 
by agitating the mixture of 10 µL of oil in 490 µL of milli-Q water without any NPs. 
Each microcalorimetric experiment consisted of 50 successive injections of a 2 µL 
solution of 10 µM β-CD NPs into the reaction cell containing 1.4 mL of oil droplets 
including each linkers. A blank experiment without the linkers was carried out as a 
control. The final titration curves were obtained by subtracting the control enthalpies 
from the sample enthalpies.  
3.4.2.3 Preparation of the buckled microparticle 
To form buckling patterns, a method similar to one for fabricating the 
microcapsule was used. However, the oil solution was changed from chloroform to a 
mixture of 95 µL of the 5 µM linker in DCPD and 5 µL of 1.5%(w/w) first-generation 
Grubbs catalyst in chloroform. In brief, 5 µL of the oil mixture was added to 495 µL of 
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the NP solution (10 µM in H2O). Then, the solution was agitated by a homogenizer 
(speed 5000 rpm for 1-2 s). After 4 h, the inner phase was completely polymerized. The 
solutions were drop-casted onto a silicon wafer and dried for 24 h under ambient 
conditions for SEM measurement. A JEOL JSM 6320F SEM was used for this 
experiment. 
3.4.2.4 Application of Cao’s model 
To plot d/R vs. R/h, data was extracted from the SEM images (Table 3.3-3.5 and 
Figure 3.17 – 3.38). The diameter (2R) was determined by averaging five measurements 
and the wavelengths (d) were measured as the averaged spacing between the lowest 
points of neighboring buckles from the SEM images using Image J software. Power-law 
relationship fittings were carried out at both fixed (-0.8) and unfixed values of b. 
  
Table 3.3 Various values of d/R depending on the values of R/h in the microparticles 
composed of the AB-Hex-AB linkers. 
 
AB-Hex-AB 
image # R/h S.D.(R/h) d/R S.D.(d/R) 
#1 138.23389 4.9672871 0.016204637 0.001762922 
#2 61.7509 0.578417845 0.022448499 0.001585749 
#3 108.30811 4.559272352 0.017583817 0.001728647 
#4 82.98596 1.055981852 0.020256981 0.003103911 
#5 81.54808 1.52656136 0.020092319 0.001824705 
#6 173.65532 2.5724871 0.016161929 0.002810976 
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Image #1 Diameter 
 
Image #1 Wavelength 
1 2847.339 1 22.179 
2 2646.48 2 19.617 
3 2719.456 3 20.946 
4 2886.815 4 25.958 
5 2723.299 5 25.227 
Average 2764.6778 6 22.06 
Radius 1382.3389 7 21.124 
S.D. 49.672871 8 22.06 
#1 
 
9 18.518 
10 20.946 
11 24.135 
12 19.212 
13 20.182 
14 22.026 
15 26.88 
16 23.538 
17 25.093 
18 21.283 
19 23.933 
20 23.089 
Average 22.4003 
S.D. 2.3001820 
Average 
(d/R) 0.016204637 
S. D. (d/R) 0.001762922 
 
Figure 3.17 The value of d/R and the radius of the microparticle composed of AB-Hex-
AB linkers from SEM image #1. 
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Image #2 Diameter 
 
Image #2 Wavelength 
1 1228.438 1 14.92 
2 1236.824 2 13.06 
3 1254.229 3 14.638 
4 1230.581 4 14.541 
5 1225.018 5 14.041 
Average 1235.018 6 13.736 
Radius 617.509 7 13.987 
S.D. 5.784178453 8 12.529 
#2 
 
9 13.849 
10 15.462 
11 14.234 
12 15.007 
13 14.845 
14 13.711 
15 12.747 
16 13.81 
17 12.05 
18 13.06 
19 14.008 
20 13.008 
Average 13.86215 
S.D. 0.905770755 
Average 
(d/R) 0.022448499 
S.D. (d/R) 0.001481809 
 
Figure 3.18 The value of d/R and the radius of the microparticle composed of AB-Hex-
AB linkers from SEM image #2. 
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Image #3 Diameter 
 
Image #3 Wavelength 
1 2269.567 1 19.016 
2 2100.348 2 18.432 
3 2170.752 3 20.981 
4 2052.001 4 19.122 
5 2238.143 5 17.432 
Average 2166.1622 6 16.788 
Radius 1083.0811 7 17.376 
S.D. 45.59272352 8 17.039 
#3 
 
9 20.392 
10 18.041 
11 18.291 
12 18.377 
13 18.291 
14 19.6 
15 24.194 
16 17.039 
17 18.824 
18 18.222 
19 20.392 
20 20.041 
Average 19.0447 
S.D. 1.691939936 
Average 
(d/R) 0.017583817 
S.D.(d/R) 0.001728647 
Figure 3.19 The value of d/R and the radius of the microparticle composed of AB-Hex-
AB linkers from SEM image #3. 
 
 
 
 
 
 
	  74 
 
 
 
 
 
 
Image #4 Diameter 
 
Image #4 Wavelength 
1 1672.239 1 12.935 
2 1663.416 2 19.282 
3 1686.204 3 21.446 
4 1637.823 4 21.21 
5 1638.914 5 17.268 
Average 1659.7192 6 17.257 
Radius 829.8596 7 17.759 
S.D. 10.55981852 8 18.224 
#4 
 
9 16.182 
10 15.223 
11 15.973 
12 19.402 
13 15.522 
14 15.656 
15 16.489 
16 14.462 
17 19.787 
18 11.839 
19 16.11 
20 14.183 
Average 16.81045 
S.D. 2.566912552 
Average 
(d/R) 0.020256981 
S.D.(d/R) 0.003103911 
Figure 3.20 The value of d/R and the radius of the microparticle composed of AB-Hex-
AB linkers from SEM image #4. 
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Image #5 Diameter 
 
Image #5 Wavelength 
1 1614.446 1 16.01 
2 1625.999 2 16.876 
3 1668.121 3 19.014 
4 1592.077 4 16.401 
5 1654.165 5 20.282 
Average 1630.9616 6 17.109 
Radius 815.4808 7 16.652 
S.D. 15.2656136 8 16.231 
#5 
 
9 14.063 
10 16.352 
11 16.072 
12 17.52 
13 14.479 
14 16.604 
15 16.509 
16 16.616 
17 15.094 
18 14.369 
19 15.873 
20 15.572 
Average 16.3849 
S.D. 1.456057109 
Average 
(d/R) 0.020092319 
S.D.(d/R) 0.001824705 
Figure 3.21 The value of d/R and the radius of the microparticle composed of AB-Hex-
AB linkers from SEM image #5. 
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Image #6 Diameter 
 
Image #6 Wavelength 
1 3502.064 1 23.799 
2 3441.588 2 29.61 
3 3499.163 3 21.449 
4 3398.903 4 23.501 
5 3523.814 5 25.216 
Average 3473.1064 6 27.678 
Radius 1736.5532 7 25.087 
S.D. 25.724871 8 23.593 
#6 
 
9 21.076 
10 35.016 
11 37.745 
12 23.163 
13 31.749 
14 33.914 
15 32.089 
16 32.359 
17 26.279 
18 33.088 
19 28.028 
20 26.882 
Average 28.06605 
S.D. 4.863670516 
Average 
(d/R) 0.016161929 
S.D.(d/R) 0.002810976 
Figure 3.22 The value of d/R and the radius of the microparticle composed of AB-Hex-
AB linkers from SEM image #6. 
 
 
 
 
 
 
	  77 
 
 
 
 
Table 3.4 Various values of d/R depending on the values of R/h in the microparticles 
composed of the AB-Hex-AD linkers. 
 
AB-Hex-AD 
image # R/h Stdv(R/h) d/R Stdv(d/R) 
#7 85.46616 4.348917472 0.065200835 0.006687877 
#8 66.84316 2.731984478 0.076192089 0.009942082 
#9, #10 66.72924 4.724364627 0.075044463 0.012734324 
#11, #12 184.5207 13.42746652 0.041601755 0.006505563 
#13, #14 120.76362 5.702248073 0.050591478 0.0047888 
#15 64.89466 2.423910545 0.078659169 0.011952579 
#16 75.23311 2.29966144 0.072473808 0.009165507 
#17 120.26083 13.7778451 0.051434495 0.009698906 
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Image #7 Diameter 
 
Image #7 Wavelength 
1 1842.928 1 57.549 
2 1697.16 2 45.064 
3 1645.611 3 53.378 
4 1623.287 4 57.068 
5 1737.63 5 65.576 
Average 1709.3232 6 50.811 
Radius 854.6616 7 50.22 
S.D. 43.48917472 8 54.727 
#7 
 
9 53.378 
10 57.269 
11 52.325 
12 54.147 
13 58.616 
14 64.722 
15 58.938 
16 50.822 
17 58.624 
18 61.677 
19 54.698 
20 54.884 
Average 55.72465 
S.D. 4.962958533 
Average 
(d/R) 0.065200835 
S.D.(d/R) 0.006687877 
Figure 3.23 The value of d/R and the radius of the microparticle composed of AB-Hex-
AD linkers from SEM image #7. 
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Image #8 Diameter 
 
Image #8 Wavelength 
1 1355.64 1 57.107 
2 1416.295 2 54.233 
3 1305.925 3 54.233 
4 1271.133 4 50.649 
5 1335.323 5 49.19 
Average 1336.8632 6 58.381 
Radius 668.4316 7 39.216 
S.D. 27.31984478 8 56.191 
#8 
 
9 54.113 
10 64.572 
11 54.946 
12 51.131 
13 47.466 
14 44.383 
15 42.418 
16 41.048 
17 49.137 
18 46.123 
19 53.922 
20 50.125 
Average 50.9292 
S.D. 6.311192577 
Average 
(d/R) 0.076192089 
S.D.(d/R) 0.009942082 
Figure 3.24 The value of d/R and the radius of the microparticle composed of AB-Hex-
AD linkers from SEM image #8. 
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Image #9,10 Diameter 
 
Image 
#9,10 Wavelength 
1 1327.098 1 41.191 
2 1482.73 2 46.763 
3 1229.116 3 48.704 
4 1285.641 4 41.191 
5 1348.339 5 56.611 
Average 1334.5848 6 52.75 
Radius 667.2924 7 54.404 
S.D. 47.2436462 8 52.571 
#9 
 
9 52.821 
10 61.801 
11 59.406 
12 54.404 
13 58.704 
14 60.693 
15 45.357 
16 45.729 
17 34.738 
18 42.633 
19 39.347 
20 51.714 
Average 50.0766 
S.D. 7.722572726 
Average 
(d/R) 0.075044463 
S.D.(d/R) 0.012734324 
#10 
 
Figure 3.25. The value of the d/R and 
the radius of the microparticle 
composed of AB-Hex-AD linkers 
from SEM images #9 and #10. 
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Image   
#11, 12 Diameter 
 
Image 
#11,12 Wavelength 
1 3773.803 1 76.298 
2 3342.021 2 59.585 
3 4023.748 3 77.847 
4 3809.052 4 75.26 
5 3503.446 5 80.499 
Average 3690.414 6 66.569 
Radius 1845.207 7 73.98 
S.D. 134.2746652 8 90.139 
#11 
 
9 95.015 
10 91.667 
11 77.083 
12 79.276 
13 91.001 
14 76.83 
15 75.289 
16 67.604 
17 79.55 
18 80.039 
19 70.032 
20 51.714 
Average 76.76385 
S.D. 10.62518716 
Average 
(d/R) 0.041601755 
S.D.(d/R) 0.006505563 
#12 
 
Figure 3.26 The value of d/R and the 
radius of the microparticle composed of 
AB-Hex-AD linkers from SEM images 
#11 and #12. 
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Image 
#13,14 Diameter 
 
Image 
#13,14 Wavelength 
1 2357.312 1 63.805 
2 2526.381 2 58.046 
3 2293.852 3 65.489 
4 2351.309 4 60.371 
5 2547.508 5 64.371 
Average 2415.2724 6 61.684 
Radius 1207.6362 7 60.496 
S.D. 57.02248073 8 66.224 
#13 
 
9 57.602 
10 62.729 
11 64.47 
12 61.395 
13 54.332 
14 61.613 
15 70.677 
16 52.174 
17 67.724 
18 51.883 
19 61.266 
20 55.571 
Average 61.0961 
S.D. 5.012205722 
Average 
(d/R) 0.050591478 
S.D.(d/R) 0.0047888 
#14 
 
Figure 3.27 The value of d/R and the 
radius of the microparticle composed 
of AB-Hex-AD linkers from SEM 
images #13 and #14. 
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Image #15 Diameter 
 
Image #15 Wavelength 
1 1310.536 1 59.755 
2 1350.939 2 48.637 
3 1315.115 3 43.236 
4 1219.742 4 43.339 
5 1293.134 5 37.792 
Average 1297.8932 6 58.852 
Radius 648.9466 7 38.942 
S.D. 24.23910545 8 50.621 
#15 
 
9 49.233 
10 49.53 
11 53.936 
12 44.006 
13 61.658 
14 59.438 
15 45.137 
16 60.679 
17 61.624 
18 51.729 
19 52.355 
20 50.413 
Average 51.0456 
S.D. 7.518602708 
Average 
(d/R) 0.078659169 
S.D.(d/R) 0.011952579 
Figure 3.28 The value of d/R and the radius of the microparticle composed of AB-Hex-
AD linkers from SEM image #15.  
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Image #16 Diameter 
 
Image #16 Wavelength 
1 1492.79 1 51.22 
2 1536.193 2 49.69 
3 1453.556 3 39.588 
4 1566.321 4 50.137 
5 1474.451 5 46.849 
Average 1504.6622 6 52.411 
Radius 752.3311 7 59.288 
S.D. 22.9966144 8 60.661 
#16 
 
9 48.609 
10 59.085 
11 55.556 
12 50.85 
13 61.558 
14 59.085 
15 58.94 
16 55.06 
17 48.077 
18 60.914 
19 53.99 
20 68.918 
Average 54.5243 
S.D. 6.691048499 
Average 
(d/R) 0.072473808 
S.D.(d/R) 0.009165507 
Figure 3.29 The value of d/R and the radius of the microparticle composed of AB-Hex-
AD linkers from SEM image #16. 
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Image #17 Diameter 
 
Image #17 Wavelength 
1 2794.644 1 54.194 
2 2104.506 2 66.974 
3 2529.988 3 56.884 
4 2190.562 4 61.47 
5 2406.383 5 72.582 
Average 2405.2166 6 69.411 
Radius 1202.6083 7 57.032 
S.D. 137.778451 8 57.765 
#17 
 
9 68.557 
10 73.988 
11 50.663 
12 63.887 
13 70.583 
14 73.217 
15 43.466 
16 75.48 
17 47.518 
18 57.749 
19 59.206 
20 56.485 
Average 61.85555 
S.D. 9.264401298 
Average 
(d/R) 0.051434495 
S.D.(d/R) 0.009698906 
Figure 3.30 The value of d/R and the radius of the microparticle composed of AB-Hex-
AD linkers from SEM image #17. 
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Table 3.5 Various values of d/R depending on the values of R/h in the microparticles 
composed of the AD-Hex-AD linkers. 
 
AD-Hex-AD 
image # R/h Stdv(R/h) d/R Stdv(L/R) 
#18 168.45644 3.331034023 0.103790392 0.004905531 
#19, #20 246.48392 3.238083654 0.079548901 0.007693427 
#21 171.28212 2.053057826 0.105438268 0.006147481 
#22 156.88339 2.42590913 0.11416591 0.02750209 
#23 142.44883 4.150787885 0.120947255 0.016977347 
#24, #25 194.4163 4.347369103 0.093701068 0.006908858 
#26 183.09545 3.242880869 0.097768869 0.004997992 
#27 233.26228 5.817664275 0.082526223 0.004660982 
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Image #18 Diameter 
 
Image #18 Wavelength 
1 3463.865 1 170.537 
2 3348.666 2 177.617 
3 3286.127 3 168.25 
4 3346.733 4 173.946 
5 3400.253 5 184.426 
Average 3369.1288 6 182.565 
Radius 1684.5644 7 181.85 
S.D. 33.31034023 8 170.488 
#18 
 
9 174.794 
10 178.492 
11 171.359 
12 165.291 
13 176.15 
14 178.222 
15 192.952 
16 171.265 
17 160.247 
18 176.178 
19 178.953 
20 163.25 
Average 174.8416 
S.D. 7.50570378 
Average 
(d/R) 0.103790392 
S.D.(d/R) 0.004905531 
Figure 3.31 The value of d/R and the radius of the microparticle composed of AD-Hex-
AD linkers from SEM image #18. 
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Image   
#19, 20 Diameter 
 
Image  
#19, 20 Wavelength 
1 4953.939 1 199.683 
2 4925.792 2 204.249 
3 4861.837 3 219.261 
4 4881.15 4 210.367 
5 5025.674 5 192.373 
Average 4929.6784 6 197.163 
Radius 2464.8392 7 196.352 
S.D. 32.38083654 8 226.469 
#19 
 
9 183.8 
10 193.8 
11 200.731 
12 219.731 
13 174.161 
14 215.692 
15 219.967 
16 182.871 
17 154.8 
18 186.209 
19 176.789 
20 181.576 
Average 196.07525 
S.D. 18.78730016 
Average 
(d/R) 0.079548901 
S.D.(d/R) 0.007693427 
#20 
 
Figure 3.32 The value of d/R and the radius 
of the microparticle composed of AD-Hex-
AD linkers from SEM images #19 and #20. 
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Image  
#21 Diameter 
 
Image  #21 Wavelength 
1 3442.667 1 184.944 
2 3471.516 2 181.532 
3 3369.107 3 178.07 
4 3398.656 4 186.77 
5 3446.266 5 197.537 
Average 3425.6424 6 172.54 
Radius 1712.8212 7 182.316 
S.D. 20.53057826 8 193.361 
#21 
 
9 172.597 
10 173.947 
11 191.907 
12 173.131 
13 178.659 
14 186.992 
15 185.185 
16 168.082 
17 151.041 
18 188.101 
19 175.924 
20 189.302 
Average 180.5969 
S.D. 10.3046191 
Average 
(d/R) 0.105438268 
S.D.(d/R) 0.006147481 
Figure 3.33 The value of d/R and the radius of the microparticle composed of AD-Hex-
AD linkers from SEM image #21. 
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Image  
#22 Diameter 
 
Image  #22 Wavelength 
1 3189.992 1 228.496 
2 3068.752 2 246.501 
3 3129.897 3 195.727 
4 3121.816 4 191.82 
5 3177.882 5 136.654 
Average 3137.6678 6 157.104 
Radius 1568.8339 7 185.789 
S.D. 24.2590913 8 169.323 
#22 
 
9 225.888 
10 239.459 
11 221.735 
12 249.701 
13 139.491 
14 157.261 
15 154.382 
16 115.604 
17 115.364 
18 129.476 
19 141.927 
20 180.445 
Average 179.10735 
S.D. 43.0572294 
Average 
(d/R) 0.11416591 
S.D.(d/R) 0.02750209 
Figure 3.34 The value of d/R and the radius of the microparticle composed of AD-Hex-
AD linkers from SEM image #22. 
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Image  
#23 Diameter 
 
Image  #23 Wavelength 
1 2881.9 1 169.535 
2 2796.079 2 177.778 
3 2733.346 3 171.436 
4 2893.119 4 102.213 
5 2940.439 5 214.321 
Average 2848.9766 6 211.877 
Radius 1424.4883 7 169.82 
S.D. 41.50787885 8 181.028 
#23 
 
9 171.144 
10 172.58 
11 185.447 
12 167.037 
13 174.448 
14 186.67 
15 153.081 
16 151.586 
17 186.608 
18 191.506 
19 167.244 
20 140.4 
Average 172.28795 
S.D. 23.65722631 
Average 
(d/R) 0.120947255 
S.D.(d/R) 0.016977347 
Figure 3.35 The value of d/R and the radius of the microparticle composed of AD-Hex-
AD linkers from SEM image #23. 
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Image   
#24, 25 Diameter 
 
Image   
#24, 25 Wavelength 
1 3895.504 1 182.168 
2 3871.977 2 199.603 
3 3772.238 3 185.146 
4 4016.527 4 171.153 
5 3885.384 5 185.453 
Average 3888.326 6 162.39 
Radius 1944.163 7 187.825 
S.D. 43.47369103 8 179.254 
#24 
 
9 189.626 
10 187.313 
11 187.667 
12 159.468 
13 165.413 
14 197.148 
15 191.88 
16 171.717 
17 179.626 
18 161.144 
19 199.626 
20 199.783 
Average 182.17015 
S.D. 12.79935601 
Average 
(d/R) 0.093701068 
S.D.(d/R) 0.006908858 
#25 
 
Figure 3.36 The value of d/R and the 
radius of the microparticle composed 
of AD-Hex-AD linkers from SEM 
images #24 and #25. 
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Image  
#26 Diameter 
 
Image  #26 Wavelength 
1 3682.64 1 172.562 
2 3671.05 2 172.397 
3 3570.77 3 185.45 
4 3747.903 4 183.45 
5 3637.182 5 173.191 
Average 3661.909 6 173.206 
Radius 1830.9545 7 195.411 
S.D. 32.42880869 8 186.452 
#26 
 
9 192.348 
10 178.023 
11 166.248 
12 185.45 
13 185.526 
14 166.884 
15 167.357 
16 177.191 
17 173.275 
18 187.626 
19 171.45 
20 186.71 
Average 179.01035 
S.D. 8.584306182 
Average 
(d/R) 0.097768869 
S.D.(d/R) 0.004997992 
Figure 3.37 The value of d/R and the radius of the microparticle composed of AD-Hex-
AD linkers from SEM image #26. 
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Image  
#27 Diameter 
 
Image  #27 Wavelength 
1 4718.717 1 197.025 
2 4618.203 2 181.734 
3 4499.695 3 197.94 
4 4811.938 4 180.344 
5 4677.675 5 188.471 
Average 4665.2456 6 208.09 
Radius 2332.6228 7 182.375 
S.D. 58.17664275 8 184.127 
#27 
 
9 200.825 
10 188.696 
11 183.312 
12 194.759 
13 188.989 
14 218.673 
15 192.163 
16 187.37 
17 180.607 
18 194.646 
19 198.673 
20 201.232 
Average 192.50255 
S.D. 9.754825434 
Average 
(d/R) 0.082526223 
S.D.(d/R) 0.004660982 
Figure 3.38 The value of d/R and the radius of the microparticle composed of AD-Hex-
AD linkers from SEM image #27. 
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CHAPTER 4 
 
 
 
 
NANOPARTICLE DENDRIMER HYBRID NANOCAPSULES FOR IN VIVO 
DRUG DELIVERY  
4.1 Introduction 
Two-dimensional porous structures offer a pliable platform for controlling 
molecular interactions. 1 , 2 , 3  Porous nanomaterials have been used in a variety of 
applications such as catalysis, 4 , 5  bio-molecules separation, 6 , 7  and drug delivery. 8 , 9 
Permeable architectures create geometrically restrictive environments for controlling 
structure-substrate interactions.10,11 This behavior can be tuned through modulation of 
pore size as well as of structure surface functionalities. 12 , 13 , 14 , 15  Furthermore, the 
properties of the components used to generate the porous matrix can be readily 
incorporated into the overall functionality of the system.16,17   
Translating the behavior of two-dimensional porous structures into functional, 
nanometer- sized three-dimensional structures is challenging. The most commonly used 
approach is to confine the assembly of inorganic precursors and porogens into 
nanometer-sized templates.18  Mesoporous silica nanoparticles have been widely used as 
nanosized structures with tunable permeability.19,20 For example, Zink and Stoddart have 
demonstrated that directed supramolecular assemblies can be used to control the release 
of encapsulated cargo from mesoporous silica nanoparticles.21,22,23,24 Supramolecular-
based assembly methods are particularly attractive for generating porous materials as the 
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assembly is self-sorting and creates discrete structures.25,26 Taken together, controlling 
the dimensions and payload interactions at the surface of permeable carriers is crucial to 
improve the performance of porous nanomaterials.   
Previously, we have demonstrated that synthetic biomimetic membranes provide 
an effective way to control the release of payloads from two-dimensional therapeutic 
reservoirs.27, 28 We hypothesized that these thin film membranes could be wrapped 
around an interfacial core to form a permeable drug delivery vehicle. Herein, we describe 
the fabrication of three-dimensional, porous nanostructures through the self-assembly of 
nanoparticles and dendrimers at the surface of therapeutic oil droplets. This multimodal 
self-assembly is driven by therapeutic emulsions acting as three-dimensional templates 
for the vehicles’ overall structure.  In our design, cationic gold nanoparticles self-
assemble at the surface of the oil droplets complex and are covalently crosslinked by 
anionic dithiocarbamate functionalized dendrimers generating a porous film at the 
oil/water interface (Figure 4.1).  The release behavior and stability of the nanoparticle 
dendrimer hybrid nanocapsules (NDHCs) was controlled by adjusting the molar ratio 
between dendrimer linkers and nanoparticles.  This superimposed membrane approach 
was used to create structures with a high payload to carrier ratio that was shown to be an 
effective in vivo drug delivery vehicle. 
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Figure 4.1 Schematic illustration of formation of (a) dithiocarbamate functionalized 
dendrimers and (b) NDHCs. The dithiocarbamate functionalized dendrimers as 
crosslinkers were fabricated by the interfacial reaction between PAMAM dendrimer and 
CS2 and the crosslinkers bound to the cores of nanoparticles, forming the nanoparticle-
dendrimer composite film at the interface. (c) A TEM image of the dried NDHC. (d) A 
SEM images of the dried NDHC.    
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4.2 Results and discussion  
4.2.1 Fabrication of nanoparticle-dendrimer hybrid nanocapsules (NDHCs)  
 Our previous study demonstrated that arginine functionalized gold nanoparticles 
(Arg-AuNPs) can effectively stabilize ~100 nm sized linoleic acid emulsions to form 
stable therapeutic capsules.29  To enhance the utility of the vehicles, we hypothesized that 
by tuning the lateral interactions between nanoparticles at the oil/water interface we could 
modulate the stability and drug release behavior of the capsules.  Furthermore by using 
the emulsion as a template for directing the crosslinking with dithiocarbamate 
functionalized dendrimers robust nanoparticle-polymer composite films should assemble 
at the interface. The assembly strategy is depicting in Figure 4.1.  First, the 
dithiocarbamate functional dendrimers were synthesized through the reaction of 
poly(amido amine) (PAMAM) dendrimers and CS2 in a biphasic system 
(water:dichloromethane, pH=10, Figure 1a). After synthesizing the crosslinkers, 
nanoparticle-stabilized Pickering emulsions (NSPEs, diameter=100 nm) were fabricated 
separately and then incubated with the crosslinkers to form nanoparticle-dendrimer 
hybrid capsules (NDHC) (Figure 4.1b). Transmission electron microscopy (TEM) and 
scanning electron microscopy (SEM) indicate that the NDHCs can preserve a stable 
three-dimensional structure after drying and their original sizes (~ 100 nm) (Figure 
4.1c,d). We hypothesized that the rate of drug release could be regulated by the molar 
ratio between nanoparticles and dendrimer linkers or the generation of dendrimers like 
the two-dimensional nanoparticle-dendrimer films. 
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Maintaining the size of a colloidal delivery vehicle is paramount if it is to harness 
the enhanced permeation and retention effect. In order to maintain the nanometer sized 
capsules while introducing the dendrimers’ functionality, we first set out to determine the 
effect the Arg-AuNP:dendrimer ratio would have on the size of the capsules. As shown in 
Figure 4.2, when the AuNP:dendrimer molar ratio was below 1:16, the diameter of the 
NDHCs remained fairly constant (100 nm), regardless of the generation of the dendrimer 
crosslinker used (generation 2 or 4). We assumed that a molar ratio of the dendrimer 
linker to nanoparticle exceeding 1:16 caused inter-capsule crosslinking. These 
observations demonstrated that the NDHCs could be fabricated in the range from 1 to 16 
of dendrimer molar concentrations and preserve capsule size.  
 
Figure 4.2 The diameters of the NDHCs fabricated by various molar ratios when 
generation 2 dendrimers (a) and generation 4 dendrimers (b) were used. 
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4.2.2 Stability of nanoparticle-dendrimer hybrid nanocapsules (NDHCs) 
 Long term stability of capsules dictates how the vehicle will perform in biological 
applications.  We investigated the stability of NDHCs fabricated by various 
concentrations and generations of dendrimers to determine the optimal conditions. To 
probe the colloidal stability of the NDHCs, the diameter of NDHCs in sodium phosphate 
buffer (5 mM, pH 7.4) was monitored after 24 h of incubation (Figure 4.3). While the 
diameter of NDHCs fabricated by using second-generation dendrimer linkers was 
increased, fourth-generation dendrimer linkers provided excellent stability regardless of 
the concentration of the linkers.  We assumed that the fourth-generation (G4) dendrimer 
linkers would provide more linkages between the Arg-AuNPs with their larger size 
allowing their functional groups to reach the gold cores more effectively than second-
generation (G2) dendrimer linkers creating a more stable vehicle.  Based on this result, a 
fourth-generation dendrimer linker was chosen for the fabrication of NDHCs for 
subsequent drug delivery studies.  
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Figure 4.3 The diameters of the NDHCs fabricated by AuNP:Dendrimer(G2 and G4) 1:1, 
1:4, and 1:16 in water before / after 24 h. 
We next probed the degree to which the molar ratio of G4 dendrimer:Arg-AuNP 
would affect the stabilities of the capsules.  To remove the interfacial tension between 
linoleic acid and water and disrupt the capsule structure, 20 % v/v of ethanol was added 
to the NDHCs solutions, and the diameters of the NDHCs fabricated by various 
dendrimer molar ratios (Arg-AuNPs:dendrimer linker; 1:1, 1:4, and  1:16) were  
monitored in terms of incubation time.  While the diameters of the NSPEs increased as a 
function of time, the diameters of the NDHCs were preserved (Figure 4.4 a,c, Figure 4.5). 
To confirm these results, TEM images of the NDHCs and the NSPEs after 24 hour of 
incubation in water/ethanol were obtained. As shown in Figure 3b the NDHCs could 
preserve their shape and size, whereas only nanoparticle aggregates were observed in the 
TEM image, Figure 3d, of the NSPEs. Additionally, the stability of the NDHCs in the 
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presence of surfactant molecules (sodium dodecyl sulfate, 0.1M) was monitored. Unlike 
for the NSPEs, the diameter of the NDHCs was preserved (Figure 4.6). These results 
strongly suggest that the Arg-AuNPs were densely crosslinked at the interface and this 
crosslinking formed a nanoparticle dendrimer composite shell.  The stability of NDHCs 
in biological condition (DMEM media with 10% serum) was monitored via checking the 
hydrodynamic diameter. During the 18 h, the NDHCs (1:4, G4 dendrimer) could preserve 
their shape and size, showing their biological stability (Figure 4.4e).  
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Figure 4.4 (a) The diameter of the NDHCs fabricated by AuNP:dendrimer(G4) 1:4 in 
water/ethanol (8:2.v/v) in terms of incubation time. (b) The TEM image of NDHCs after 
24 h incubation in water/ethanol (8:2, v/v). (c) The diameter of the NSPEs in 
water/ethanol (8:2.v/v) in terms of incubation time. (d) The TEM image of NSPEs after 
24 h incubation in water/ethanol (8:2, v/v). (e) The diameter change of the NDHCs 
fabricated by AuNP:dendrimer(G4) 1:4 in DMEM media with 10 % serum for 18 h.  
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Figure 4.5 The diameter of the NDHCs fabricated by AuNP:Dendrimer(G4) 1:1 and 1:16 
in water/ethanol (8:2.v/v) in terms of incubation time. 
 
 
Figure 4.6 The diameter of the NDHCs before / after the incubation of 0.1 M SDS 
solution.  
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4.2.3 Controlled drug release of nanoparticle-dendrimer hybrid nanocapsules 
(NDHCs) 
Control over payload release is crucial to use the capsule structure as a drug 
delivery carrier. NDHCs fabricated by different molar ratios of G4 dendrimer linker were 
explored to control the drug release profile. As we hypothesized, applying different 
dendrimer linker molar ratios affected the drug release profile of the NDHCs. Higher 
molar ratios of dendrimer linkers provided an environment in which the hydrophobic 
drugs (paclitaxel (PTX)) tend to remain in the shell of the NDHCs, decreasing drug 
release (Figure 4.7). Therefore, the drug release profile of the NDHCs can be tuned 
simply by tuning the dendrimer linker molar ratio. 
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Figure 4.7 Drug release profiles of NDHCs fabricated by using different dendrimer 
molar ratios in terms of time. Higher molar ratio of dendrimer reduced the rate of drug 
release than lower molar ratio. Through the control of the molar ratio of dendrimer, the 
drug release profile can be simply tuned. 
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4.2.4 Mechanism of drug release of nanoparticle-dendrimer hybrid capsules 
(NDHCs) 
To visualize the delivery cross-sectional cell-TEM images of B16F10 and MCF-7 
cells incubated for 3 h with NDHCs or NSPEs were obtained. The NDHCs could 
preserve their shape and size after being taken up by cells (Figure 4.8 a-c). However, 
TEM images of the cells incubated with NSPEs showed only nanoparticle aggregates 
(Figure 4.8d). Significantly, Figure 4.8e shows the early process of endocytosis of 
nanoparticle aggregates, indicating that the NSPEs were converted to nanoparticle 
aggregates before the capsules had been taken up by cells. These results indicate that 
NDHCs are stable and can protect their cargos during the cellular uptake process. To 
tracking the cargo and carrier during the cellular uptake process, we first encapsulated the 
fluorescent dye (Nile red) into NDHCs and treated in B16F10 and MCF-7 cells in terms 
of incubation time (30, 60, 360 min). Cytoflow metry and inductively coupled plasma 
mass spectroscopy (ICP-MS) were used for tracking the intensity of released dye and 
amount of gold inside cells, respectively. The NSPEs treated cells were also investigated 
for comparison. In the NDHCs treated cells, the ratio between the intensity of the 
fluorescence and the gold amount was relatively constant regardless of the incubation 
time while the result of the NSPE treated cells showed the fluctuation of the ratio 
depending on the incubation time (Figure 4.9, 4.10). In previous studies, we suggested 
that NSPE used the membrane fusion mechanism for delivery, showing the cargos first 
delivered to the cells and the carriers slowly were uptaken by the cell.29, 30. Unlike 
NSPEs, NDHCs were taken up by cells and the dyes were then released from the carrier. 
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The enhanced stability and controlled drug release of NDHCs changed the delivery 
pattern, preventing premature release of drugs before the carrier arrives at the target sites.    
  
 
Figure 4.8 (a, b) TEM images of cross-sectional B16F10 cells incubated for 24 h with 
NDHCs, (c) TEM images of cross-sectional MCF-7 cells incubated for 24 h with  (a) 
NDHCs  and  (d,e) NSPEs.  
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Figure 4.9 The mean value of fluorescence intensity of cells treated with  (a) NSPEs or 
(c) NDHCs. The mean values were obtained by flow cytometry. Quantification of the 
amount of gold present in cells treated with  (b) NSPEs or (d) NDHCs. Samples were 
analyzed by ICP-MS to determine the amount of gold in B16F10 cells after various 
incubations. 
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Figure 4.10 The mean value of fluorescence intensity of cells treated with  (a) NSPEs or 
(c) NDHCs. The mean values were obtained by flow cytometry. Quantification of the 
amount of gold present in cells treated with  (b) NSPEs or (d) NDHCs. Samples were 
analysed by ICP-MS to determine the amount of gold in MCF-7 cells after various 
incubations. 
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4.2.5 Nanoparticle-dendrimer hybrid nanocapsule (NDHC) as a drug carrier 
Based on the drug release and stability results, we chose the NDHCs fabricated by 
G4 dendrimer linker with 1:4 molar ratio (NP: G4 dendrimer). Cytotoxicity of both 
NDHCs and PTX-loaded NDHCs was evaluated in mammalian cancer cells such as 
MCF-7 and B16F10 cells using Alamar Blue assay. Using a cell viability assay, NDHC 
showed no cytotoxic effect on mammalian cells (Figure 4.11). However, the PTX (10 
mg/mL)-loaded NDHCs showed an anticancer effect to both cancer cell types. These 
results demonstrate that the NDHC itself could be a potential drug carrier, capable of a 
high-loading efficiency of PTX due to its oil core and could effectively deliver PTX to 
any type of cancer cells.  
 
Figure 4.11 Cytotoxicity of NDHCs and PTX-loaded NDHCs measured by Alamar blue 
assay after 24 h incubation in (a) B16F10 and (b) MCF-7 cells. No cytotoxicity of 
NDHCs was observed up to 0.3 nM of NDHCs. However, the PTX-loaded NDHCs 
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showed the Cell viability experiments were performed as triplicate and the error bars 
represent the standard deviations of these measurements.  
 The antitumor effect of PTX-loaded NDHC was evaluated in a B16F10 
melanoma tumor model. C57BL6 mice were treated with PBS, PTX, the NDHC or PTX-
loaded NDHC. As a result, PTX-loaded NDHC significantly inhibited tumor growth 
compared to the PTX-treated group, indicating that the NDHCs possess the ability to 
passively target tumors (Figure 4.12). Tumor volume showed no increase after the second 
administration of the PTX-loaded NDHC, but the mice in the control groups including 
the PBS treated group, PTX treated group, and NDHCs without drug loading group 
showed a rapid increase of tumor volume (2-3 times). In the comparison of volume 
change of tumor of PTX treated group and PTX-loaded NDHCs treated group, the PTX 
treated group showed a rapid increase in spite of the same dose of PTX while the PTX-
loaded NDHCs showed the inhibition effect of tumor glow. This result indicates that the 
NDHCs possess the passive targeting ability. Moreover, the body weight of mice in the 
four groups remained unchanged throughout the experiment (Figure 4.13), indicating 
there is no significant side effect. These data demonstrate that NDHC effectively 
delivered hydrophobic PTX to the melanoma tumor site, creating an antitumor effect 
based on the enhanced permeation and retention effect. 
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Figure 4.12 Relative tumor volume in mice injected with the NDHCs, PTX-loaded 
NDHCs, PTX in PBS, and PBS (n = 5, mean±sem). 
 
Figure 4.13 Body weight change of mice injected with the NDHCs, PTX-loaded 
NDHCs, PTX in PBS, or PBS (n = 5, mean ± standard deviation). 
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4.3 Summary and future outlook 
 In summary, we have developed a new type of nano-sized drug delivery carrier 
having a nanoparticle-dendrimer composite shell and an oil core. By transferring a two-
dimensional nanoparticle-dendrimer composite film to a three-dimensional capsule 
structure, the resulting materials provide controlled drug release, stability, and therapeutic 
efficacy in vivo. The drug release of these NDHCs can be tuned by modulating the 
NP/dendrimer molar ratio. This interaction controlled the drug release profile and their 
stability can affect the drug release mechanism, preventing premature release of the 
drugs. The NDHCs act as a drug carrier for cancer therapy in vivo, displaying efficient 
therapeutic and passive targeting ability.  
The versatility of these NDHCs can be further enhanced through incorporation of 
targeting components into their nanoparticles or dendrimer linkers, providing an effective 
platform for drug delivery systems. These stable NDHCs also can be used in protein 
delivery or siRNA delivery. Furthermore, more functions such as on-demand drug release 
and thermal therapy can be added in this system replacing gold nanoparticle to gold 
nanorod.    
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4.4 Synthesis of materials and experimental methods  
4.4.1 Fabrication of the dithiocarbamate (DTC)-functionalized dendrimer linker 
 To synthesize the dendrimer linker, 8.8 mM of PAMAM dendrimer in a NaOH 
solution (pH ~10, 3mL) were mixed with 500 µL of CS2 in dichloromethane (3 mL). The 
mixture was stirred for 4 h at room temperature. After stirring, the linker was obtained at 
the water layer.  DTC functionalization was confirmed by checking for color change in 
the presence of Cu2+ ion (Figure 4.14). 
 
Figure 4.14 The formation of the DTC copper complexes. To check the formation of the 
dithiocarbamate function of dendrimer linker, the Cu2+ was added to the water layer 
before (a) / after (b) stirring for 4 h. The DTC functional group and Cu ion spontaneously 
formed complexes, changing the solution color from blue to green.    
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4.4.2 Fabrication of the NDHCs 
To prepare the NDHCs, 2.0 µL of linoleic acid was emulsified in 1 mL of 
arginine-functionalized nanoparticles (1.0 µM) in a phosphate buffer solution (5.0 mM, 
pH 7.4) using an amalgamator (speed 5000 rpm for 200s). This process results in oil 
droplets having a 12.8 nM concentration. Next, 200 µL of the 6.4 nM droplets were 
incubated with arginine nanoparticles (5 µM) in 800 µL phosphate buffer (5.0 mM, pH 
7.4) for 10 min. Finally, the nanocapsules were cross linked by the dithiocarbamate 
functionalized dendrimers (12.8 nM for 1:1 ratio, 51.2 nM for 1:4 ratio, and 204.8 nM for 
1:16 ratio) for 12h. To fabricate the PTX loaded NDHCs , 10 mg / mL PTX in linoleic 
acid for in vitro or 50 mg / mL PTX in linoleic acid for in vivo  drug release was used. 
4.4.3 TEM sample preparation 
 TEM samples of the NDHCs or the NSPEs were prepared by placing one drop of 
the desired capsule solution (1 nM) on a 300-mesh Cu grid coated with carbon film. 
These samples were analyzed and photographed using a JEOL CX-100 Electron 
microscope. 
4.4.4 SEM sample preparation 
SEM samples of the NDHCs were prepared by placing several drops of the 
desired capsule solution (1 nM) on a clean silicon wafer and then dried for 24h under 
ambient conditions. After drying, the samples were coated with platinum via sputtering 
for SEM imaging. A FEI Magellan 400 High-Resolution Scanning Electron microscope 
was used for this experiment.  
	  122 
4.4.5 DLS measurements 
 The size of the NDHCs or the NSPEs was measured by Dynamic Light 
Scattering. To evaluate the stability of the capsules, 20 % ethanol or 1 M SDS was added 
to the solutions.  The size of the capsules was measured on a Malvern Zetasizer Nano ZS 
instrument. 
4.4.6 In vitro release of paclitaxel 
After fabricating the NDHCs with different ratios of NP to dendrimer, each 
NDHC was first added to a dialysis cassette (Side-A-Lyzer® 3.5K, Thermoscientific, IL). 
Each dialysis cassette with the NDHCs was placed in a dark glass chamber with 30 mL of 
phosphate buffered saline (PBS, pH 7.4). The release experiment was performed at 
steady state conditions of 37°C and 100 rpm (Lab-Line® Orbit Environ-Shaker, Lab-Line 
Instruments, Inc.) for 3 days. At given time intervals, each supernatant (0.3 mL) of three 
different NDHC formulations was taken and then resuspended in 25% acetonitrile after a 
drying process (VacufugeTM, Eppendorf, Germany). Each supernatant was 
quantitatively analyzed by a high-performance liquid chromatography system (DGU-
20AS, Shimadzu, Japan). Separation was achieved using C18 reverse phase column 
(ODS, 4.6 mm x 250 mm) under a mobile phase consisting of two eluents, 0.1% 
trifluoroacetic acid (TFA) in H2O and 0.1% TFA in ACN (68:32, v/v). The flow rate was 
1 mL/min and the injection volume was 20 µL. Released paclitaxel was detected at 273 
nm using an ultraviolet (UV) detector (SPD-20AV). 
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4.4.7 Cell culture and cellular uptake experiment 
B16F10 and MCF-7 cells (American Type Culture Collection (ATCC)) were 
cultured at 37°C, 5% CO2 in a humidified atmosphere (MCO-18AC, Panasonic, Japan). 
Each cell type was grown in low glucose Dulbecco’s Modified Eagle’s Medium (DMEM, 
Gibco®, VA) supplemented with 10% fetal bovine serum and 1% antibiotic antimycotic 
solution (100 U/mL penicillin, 100 µg/mL streptomycin and 0.25 µg/mL amphotericin 
B). For subculture, cells were harvested by trypsin-EDTA solution (Cellgro, VA) before 
confluency and transferred to a new 75 cm, 2-canted neck flask. 
Both B16F10 and MCF-7 cells had been previously seeded in each 48 well-plate 
(5×104 cells/well) one day prior to a drug release mechanism experiment. Then, either 
NDHCs or NSPEs incorporating Nile red dye was added to the cells and incubated for 
different times (30, 60 and 360 min). At given time intervals, the cells were washed three 
times with PBS (pH 7.4) and trypsinized for flow cytometric anaylsis (BD LSR II, BD 
bioscience).  
In addition, B16F10 cells (1.8 x 105 cells/dish) were also cultured in glass-
bottomed dishes (MatTeck Corporation, 14 mm microwell) one day prior to confocal 
microscopy.  The next day, NDHCs incorporating the Nile red dye were incubated with 
the cells for 1 hr. Then, the cells were washed with PBS three times before taking a 
confocal image. Confocal microscopy images were assessed with a Zeiss LSM 510 Meta 
microscope using a 63x objective and the red channel (Ex=543 nm, Em=long pass 650 
nm) was used for detecting the Nile red dye. 
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4.4.8 Sample preparation for flow cytometry  
B16F10 and MCF-7 cells were cultured using Dulbecco's Modified Eagle's 
Medium (DMEM, 1 mL) and plated in 12-well microplates with a density of 40,000 
cells/well and the cells were grown for 24 hours. The Nile red encapsulated NSPEs or 
NDHCs in DMEM media were then added and incubated for 0.5, 1, and 6 h, 
respectively.. The media of the cells was removed and the cells washed with PBS (3×) to 
eliminate any extracellular capsules. After completing incubation, the cells were washed 
twice with PBS, harvested with trypsin/EDTA and resuspended in 2% FCS in PBS 
buffer. These samples were analyzed by BDTM LSR II. 
4.4.9 Cytotoxicity 
Cytotoxicity was assessed by an AlamarBlue® assay (Invitrogen, USA) 
incorporating an oxidation-reduction indicator based on detection of metabolic activity. 
Briefly, B16F10 and MCF-7 cells had been previously cultured in a 48 well plate (5x104 
cells/well), respectively. Then, each cell was incubated with either NDHC or NDHC-
PTX for 1 day. Following incubation, the cells were washed with PBS and treated with 
10% Alamar blue dye in a low glucose DMEM medium with 10% fetal bovine serum. 
After incubation, fluorescence intensity was measured (Ex: 560 nm, Em: 590 nm) using a 
SpectroMax M2 microplate reader (Molecular devices, CA) to determine cell viability. 
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4.4.10 Inductively coupled plasma mass spectrometry (ICP-MS) analysis 
After cellular uptake of NDHC or NPSC, the lysed cells were digested by 0.5 mL 
of fresh aqua regia (N.b. Highly corrosive aqua regia must be added with extreme 
caution!) for 1 hr. Each digested sample was mixed with an internal standard 103Rh (10 
ppb) and diluted to 10 mL with double-distilled water (ddH2O). A series of gold standard 
solutions ranging from 20 to 0 ppb was prepared prior to each experiment. Each gold 
standard solution also contained 5% aqua regia as well as 10 ppb of 103Rh. ICP-MS 
analyses were performed on a Perkin-Elmer NexION 300X ICP mass spectrometer as 
follows: nebulizer flow rate: 0.95-1 L/min; rf power: 1600 W; dwell time: 50 ms. 
4.4.11 Cross-sectional cell TEM 
 Cellular TEM images of the NSPEs and the NDHCs were obtained using a JEOL 
CX-100 electron microscope. All the cell TEM samples were prepared according to the 
literature.31 Briefly, MCF-7 and B16F10 cells were seeded and incubated on 15-mm-
diameter Theramanox coverslips (Nalge Nunc International) in 24-well plates (100,000 
cells per well) with 1 mL of serum containing media for 24 h before the treatment of the 
NSPEs or the NDHCs. The media was replaced by the NSPEs or the NDHCs in serum 
containing media and incubated for 3 h. The media containing NSPEs or the NDHCs was 
exchanged with new media, and the MCF7 and B16F10 cells were washed three times 
with PBS buffer. The cells treated with NSPEs or NDHCs were then fixed in 2 % 
glutaraldehyde with 3.75% sucrose in 0.1 M sodium phosphate buffer (pH 7.0) for 30 
min and washed with 0.1 M PBS containing 3.75% sucrose, three times over 30 min. The 
fixed cells were postfixed in 1% osmium tetroxide with 5% sucrose in 0.05 M sodium 
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phosphate buffer solution (pH 7.0) for 1 hour and then washed with DI water three times. 
Then, the postfixed cells were dehydrated in a graded series of acetone (10% steps) and 
embedded in epoxy resin. The resin was polymerized at 70 °C for 12 h. Ultrathin sections 
(70 nm) were obtained with a Reichert Ultracut E Ultramicrotome and then imaged under 
a JEOL CX-100 electron microscope. 
4.4.12 Animal Care 
All animal experiments were conducted in accordance with the guidelines of 
Institutional Animal Care and Use Committee (IACUC) at University of Massachusetts-
Amherst. Female C57BL6 mice (8-10 weeks, 20-25 g) were purchased from Jackson 
Laboratory (Bar Harbor, ME). Food and water intake were assessed. 
4.4.13 Intravenous administration of the NDHC in melanoma tumor-induced mice 
After one week of acclimatization, female C57BL/6 mice were anesthesized 
intraperitoneally by Avertin (tribromoetheanol, Acros, 200 mg/kg). Then, B16F10 cells 
(50 µL, 2x105 cells) were inoculated subcutaneously in the right flank after removing hair 
with a trimmer (Braintree Scientific, MA). After the tumors were allowed to grow to over 
100 mm3, mice were randomly rearranged and divided into the following groups: control 
group (saline), paclitaxel (PTX, 1 mg/kg dose)-treated group, the NDHC-treated group, 
and PTX-loaded NDHC-treated group. Each agent sample was intravenously 
administered every other day for 10 days after inducing the melanoma tumor. Changes in 
mouse weight were monitored and tumor volumes were measured by an electric digital 
caliper.  
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CHAPTER 5 
 
 
 
 
SOLUBILIZATION OF HYDROPHOBIC CATALYSTS USING 
NANOPARTICLE HOSTS  
 
 
5.1 Introduction 
 Transition metal-mediated catalysis in aqueous media is of great interest as it 
diminishes the dependence on environmentally harmful organic solvents.1 Furthermore, 
using water as a safe, low-costing, and non-toxic reaction medium2 reduces economic 
burden on chemical industries.3 However, most catalytic reactions are performed in 
organic solvents due to limited solubility,4 activity, and stability5 of the catalysts in water. 
Therefore, designing a general platform that solubilizes various hydrophobic catalysts in 
water while preserving their activity and stability, and bringing sustainability remains 
critical for environmental and economical benefits. 
 Covalent and non-covalent modifications to transition metal (TM) catalysts have 
been used to improve catalyst solubility in aqueous environments. The most widely 
investigated approaches to increase the aqueous solubility of TM catalysts are covalent 
conjugation of the catalysts with hydrophilic ligands6 or anchoring charged substituents 
to the coordinating hydrophobic ligands.7 These covalent modifications demand specific 
ligand designs for each catalyst which has been shown to affect the stability and 
reactivity of the native catalyst.8 Host–guest assembly of catalysts with cyclodextrins,9 
calixarenes,10 and cucurbiturils,11 have been shown as effective non-covalent methods to 
solubilize catalysts without the need to alter the structure of the catalysts.12 These 
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supramolecular approaches are limited by their necessity for the catalysts to possess 
suitable guest molecules within their native ligand structure.13 
Improving the solubility of TM catalysts does not inherently protect the catalysts 
from aqueous degradation. Covalent modification has been shown to change the steric 
and electronic environment of metal center which subsequently can weaken the bond 
between the water soluble ligand and the metal resulting in poor initiation efficiency, 5a 
decomposition of catalyst,14 and loss of activity.15 Supramolecular based assemblies such 
as micelles have been shown to maintain catalytic efficiency.16 However, the dynamic 
nature of micelle based systems requires fine tuning of surfactant concentration to ensure 
concentrations over their critical micelle concentration 17  and removal of excess 
surfactants after reaction is non-trivial for these water soluble platforms.18 Therefore the 
creation of a robust, generalized platform for improving catalyst solubility and stability is 
desired. 
Here, we present a facile and general method to solubilize and stabilize 
hydrophobic TM catalysts while conserving catalytic activity using a water soluble gold 
nanoparticle (AuNP) platform. A water soluble NP host was designed bearing two crucial 
features:  an aliphatic interior to create hydrophobic pockets for catalyst encapsulation 
and a water soluble exterior for aqueous solubility.19 In our method, there is no need for 
covalent modification of the catalyst, which leads to a retention of the original catalyst 
structure and activity. Furthermore, our supramolecular template supplies a protective 
niche for hydrophobic catalysts while the large surface area of the NP increases the 
accessibility of substrates to catalysts. We have studied different hydrophobic catalysts, 
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catalyzing three commercially important reactions to show the versatility of our 
supramolecular-based platform. 
 
Figure 5.1 (a) The encapsulation process of hydrophobic catalysts in water soluble NP 
hosts. (b) Schematic illustrating catalytic reaction within NP monolayer. 
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5.2 Results and discussion  
5.2.1 Encapsulation of hydrophobic catalysts in various nanoparticles and their 
encapsulation yield 
Hydrophobic TM catalysts were encapsulated using a solvent displacement 
method that is an effective and simple method followed previously to entrap hydrophobic 
drugs or dyes.19 Water soluble NP hosts and hydrophobic TM catalysts as guest 
molecules were dissolved in acetone/water or tetrahydrofuran/acetone/water mixtures and 
then the organic solvents were allowed to evaporate slowly. During the evaporation 
process, some of TM catalysts were encapsulated into the hydrophobic pockets in the 
monolayer of AuNP host and formed the catalyst-encapsulated nanoreactors (AuNP-cat), 
while excess hydrophobic catalysts were precipitated out. First, multiple filtrations were 
performed to remove non-entrapped catalysts using molecular weight cutoff filters and 
then, further purification was done through dialysis against water (Figure 5.1a). 
Entrapment of hydrophobic catalysts in the hydrophobic regions of water soluble AuNPs 
provides the catalyst aqueous solubility, while preserving catalytic activity. Mixing 
substrates with AuNP-cat yielded products in water (Figure 5.1b). Here, AuNP serves 
two roles: a water soluble host for hydrophobic catalysts and a nanoreactor for catalytic 
reactions.   
Two different sized gold cores (2 and 7 nm), each with two different ligand 
structures (TTMA and TMA, Figure 5.2a) were investigated to fabricate an efficient host 
platform with a high encapsulation profile. Both TTMA and TMA ligands posses a 
hydrophobic chain, crucial for hydrophobic pocket formation and a charged ammonium 
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head group for water solubility. However, the TTMA ligand is longer because of the 
tetraethylene glycol (TEG) unit appearing before the head group (Figure 5.2a). 
Qualitative confirmation of catalyst presence in the monolayer of NP hosts was 
monitored by 1H-NMR in D2O after encapsulation and washing steps. Peaks observed at 
around 6.8-7.8 ppm demonstrate that 2nd generation Hoveyda-Grubbs catalysts (HG2) 
were entrapped inside the NP host (Figure 5.3).  
Loaded catalyst amount in the monolayer of NP was calculated by tracking TM 
ions using KCN-induced decomposition experiments19 followed by inductively coupled 
plasma mass spectrometry (ICP-MS) measurements. The results indicate that 7 nm core 
NP hosts can hold more catalysts, however, 2 nm core NPs shows higher encapsulation 
yield according to weight ratio between catalyst and NP core (Figure 5.2b). When same 
core size but different ligand structure was considered, NP bearing TEG groups showed a 
higher catalyst loading efficiency. The surface ligand coverage was obtained using the 
laser desorption/ionization mass spectrometry20 to probe the effect of ligand coverage on 
encapsulation yield. The results revealed that the TTMA AuNPs possess more remaining 
pentane thiols after place exchange reaction than TMA AuNPs do, indicating that the 
pentane thiols provide a larger space to encapsulate the catalysts (Figure 5.4). Based on 
ICP-MS results, 2 nm core sized TTMA NP host is the most efficient one among other 
NP hosts, therefore, catalytic reactions were performed using 2 nm TTMA NPs (Figure 
5.2b).  
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Figure 5.2 (a) The structure of NP hosts (core 2 and 7 nm) and the structure of TTMA 
and TMA ligands. (b) The encapsulation efficacy of various NP hosts that have different 
core sizes and monolayer structure for HG2. 
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Figure 5.3 (a) Structure of the TTMA functionalized AuNP, (b) NMR spectrum of HG2 
catalyst encapsulated AuNP, (c) Enlarged section of NMR spectrum in the range from 6 
to 8 ppm. 
 
Figure 5.4 Ion intensity ratio of TMA and TTMA coated 2 and 7 nm AuNPs 
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The aggregation of NPs during the encapsulation and intense purification steps 
can be an issue for the stability of the nanoreactor. The size of the NP host was monitored 
before and after encapsulation of HG2 as well as after the purification process by 
transmission electron microscopy (TEM). TEM images showed no size change or 
aggregation of the NP host-HG2 compared to the NP host, displaying the stability of the 
nanoreator (Figure 5.5). 
 
 
Figure 5.5 TEM images of HG2 catalyst encapsulated AuNPs 
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5.2.2 Ring opening metathesis polymerization in water using the NP Host-HG2  
Our initial catalysis studies focused on commercially available HG2 catalyst, one 
of the most used hydrophobic catalysts for ring opening metathesis polymerization 
(ROMP). In our system, ROMP was performed in neat water by using 2 nm TTMA 
AuNP-HG2 catalyst and a positively charged norbornene monomer21 (Figure 5.6a-b). 
After 24 hours, white suspension was observed as an indication of polymer formation. 
However, when the exact same conditions except no catalyst encapsulated in the AuNPs 
was used, the solution mixture stayed clear and polymer generation was not detected 
(Figure 5.7). Effect of reaction time on polymerization was monitored by using gel 
permeation chromatography (GPC).  Polymers collected at different time points were 
characterized in terms of molecular weight and PDI (polydispersity index) (Figure 5.6d). 
Results show a typical linear trend of living polymerization that molecular weight 
increases with elevated reaction time.  Narrow PDI values were obtained as expected 
from a living ROMP reaction, indicating that our AuNP-HG2 system supplies the fine 
molecular weight control (Figure 5.6c-d and 5.11). 
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Figure 5.6 (a) The structure of 2nd generation Hoveyda-Grubbs catalyst (HG2) and HG2 
encapsulated NP hosts (NP Host-HG2). (b) The reaction scheme of ROMP using NP host 
and water soluble monomer. (c) The molecular weight and PDI values of polymers in 
terms of reaction time. (d) While the free HG2 in acetone/water mixture failed to produce. 
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Figure 5.7 Photos of the reaction mixtures including (a) NP Host or (b) NP Host-HG2 
after 24 h reactions. 
 
Catalysts containing ruthenium carbene complexes in their structure generally 
decompose quickly in aqueous solvents22 and consequently, they are unable to catalyze 
ROMP reactions. In the literature, to understand the mechanism, NMR spectroscopy was 
used to follow this decomposition process of HG2 catalyst in water/THF solutions and 
results indicated that instability originated from water coordination at ruthenium in the 
methylidene-propagating species.22 We have checked the stability of free HG2 catalyst 
and found that in the presence of monomer and free HG2 catalyst in 1:1 acetone/water 
mixture, the reaction failed to produce any polymer. Therefore, GPC could only detect 
the unreacted monomer at various reaction time points (Figure 5.6d and 5.12). However, 
HG2 catalyst embedded into the monolayer of AuNPs successfully catalyzed the ROMP 
reaction under same conditions (Figure 5.6d). From these results, we deduce that our NP 
hosts can provide a protective environment blocking water molecules from coordinating 
to metal center and as a result prevent decomposition. 
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5.2.3 Allycarbarmate cleavage using the NP host that encapsulates Cp*Ru(cod)Cl  
As a model catalyst that can catalyze cleavage reactions, the hydrophobic 
[(pentamethylcyclopentadienyl) Ru(1,5-cyclooctadiene)Cl] catalyst (Cp*Ru(cod)Cl) was 
chosen for the cleavage of allylcarbamate bonds (Figure 5.8b).23 We have quantified that 
there are 22.7 ± 1.9 Cp*Ru(cod)Cl catalysts per one NP host (Figure 5.9).  Rhodamine 
110 is a green fluorescent dye with amine functionality that can be protected with 
allylcarbamate. After caging, Rhodamine 110 becomes nonfluorescent, however, upon 
allycarbamate deprotection, strong green fluorescence is recovered as an indication of 
catalytic cleavage (Figure 5.8b and d). Reaction activity was monitored using UV 
absorbance of the Rhodamine 110 dye at a wavelength of 500 nm. While absorbance 
increased linearly in the presence of substrate (Rhodamine 110 derivative) and AuNP-
Cp*Ru(cod)Cl, it stayed constant when only AuNP and substrate were used. 
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Figure 5.8 (a) The structure of Cp*Ru(cod)Cl catalyst. (b) The reaction scheme of 
ruthenium-induced allylcarbarmate cleavage using NP hosts and non-fluorescent 
Rhodamine 110 derivative. (c) Catalytic activity of NP host- Cp*Ru(cod)Cl and only NP 
host. (d) Photographs of the reaction mixtures under UV-irradiation. 
 
	  144 
 
Figure 5.9 Quantification of encapsulated catalyst in the 2 nm TTMA-AuNP. 
 
5.2.4 Hydrogenation using the NP host that encapsulates Wilkinson catalysts and 
their reuability 
Another type of reaction we have studied for the AuNP host encapsulation 
process is the hydrogenation of alkenes.  The complex RhCl(PPh3)3 (also known as 
Wilkinson’s catalyst) is a hydrophobic, highly active catalyst for hydrogenation reactions. 
We encapsulated Wilkinson catalyst into the AuNP host and ICP-MS detected 29.7 ± 6.9 
catalysts per NP host (Figure 5.9). 0.7 mole percent of NP-Wilkinson catalyst were 
reacted with sodium 4-vinylbenzenesulfonate in water under hydrogen (3 atm) at room 
temperature for various reaction times (Figure 5.10a-b and 5.13). Reactions were 
monitored by NMR; after hydrogenation, the alkene peaks coming between 5.2-6.8 ppm 
in the NMR spectrum disappear while triplet and quartet peaks appear due to the 
formation of ethyl group. The integration of those peaks was used to calculate conversion 
percentage of the hydrogenation. Results show ~100% conversion after 24 hours of 
reaction (Figure 5.10c and 5.14). These hydrogenation experimental conditions prove the 
AuNP-cat system can effectively catalyze not only monophasic water solvent systems 
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(ROMP reaction and allylcarbamate bond breakage) but also gas-water biphasic systems 
(hydrogenation reaction). 
Catalytic reusability is an important factor in catalyzed reactions for industrial 
applications. We have examined the reusability of AuNP host-catalyst system for 
hydrogenation reaction. After the first reaction, a molecular weight cutoff filter (10 k) 
was used to separate AuNP-Wilkinson catalyst and 4-ethylbenzenesulfonate. AuNP-
Wilkinson catalyst was recovered after three times washing and reacted again with 
substrate sodium 4-vinylbenzenesulfonate under the same conditions (room temperature, 
3 atm). This cycle repeated up to five times and 100% conversion was obtained as a proof 
of recyclability the of NP-catalyst template (Figure 5.10d). 
 
 
Figure 5.10 (a) The structure of Wilkinson catalyst. (b) The reaction scheme of 
hydrogenation using NP host and sodium 4-vinylbenzenesulfonate. (c) Hydrogenation 
conversion profile in terms of reaction time for AuNP-Wilkinson. (d) Reusability test of 
AuNP-Wilkinson system for five consecutive cycles. 
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5.3 Summary and future outlook   
In summary, we have developed a versatile NP-based platform for the 
encapsulation of hydrophobic catalysts.  This supramolecular system is amenable to 
catalyzing a multitude of reactions in aqueous environments without the need to 
specifically tailor the host’s structure for each hydrophobic catalyst. The functionalized 
monolayer of the NP host serves as a phase transfer agent for the catalyst while 
concurrently preventing catalyst ‘drowning’ through supramolecular stabilization.  
Future studies will explore the use of this platform in biological systems and as 
multifunctional catalytic reactors. For example, these water-soluble catalysts can deliver 
into living cells, catalyzing the bioorthogonal reactions. Though these bioorthogonal 
reactions, we can control the bioprocesses or treat many diseases.    
 
5.4 Synthesis of materials and experimental methods  
5.4.1 Materials and Instruments 
All chemicals and materials  for the experiments were obtained from Aldrich or 
Fisher Scientific. Reaction activities were monitored by a microplate reader (Molecular 
Device SpectroMax M2) for fluorescent product (Rhodamine 110). NMR spectroscopy 
(Bruker AVANCE 400 at 400 MHz) for hydrogenation and THF GPC (Agilent 
Technologies 1260 Infinity) for ROMP reactions were used. 
5.4.2 Synthesis of TMA and TTMA coated AuNPs 
Pentanethiol-coated AuNPs with core diameter ca. 2 nm24 and 7 nm25 were 
synthesized by following Brust-Schiffrin two-phase method. AuNPs were decorated with 
TTMA or TMA ligands using Murray place-exchange method.26 For each place exchange 
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reaction, 2nm or 7 nm AuNPs (10 mg) was mixed with 27 mg of TTMA or TMA ligands 
in dry dichloromethane (DCM) for 3 days at room temperature. After reaction, solvent 
was evaporated and mixture was washed with hexane and DCM and then dialyzed 
against water. 
5.4.3 Encapsulation of the catalysts 
Catalysts (Grubbs, Cp*Ru(cod)Cl, or Wilkinson catalysts) and AuNPs were 
dissolved in an acetone/water or tetrahydrofuran/acetone/water mixture and then the 
acetone and tetrahydrofuran was slowly evaporated. During this process, most of the 
catalysts were encapsulated in monolayers and the excess hydrophobic catalysts 
precipitated.  After removing the precipitate via filtration using syringe filter (pore 
size=0.2 µm), multiple washings using a molecular-weight cutoff filter (10K) and dialysis 
against water were performed to remove all free catalysts.  
5.4.4 Quantification of the catalysts 
Quantification of catalyst in the monolayer of AuNPs was achieved by doing the 
ICP-MS analyses performed on a Perkin-Elmer NexION 300X ICP-MS spectrometer. 
197Au, 102Ru, and 103Rh were measured under the standard mode. Operating conditions 
are listed as below: nebulizer flow rate: 0.95 L/min; rf power: 1600 W; plasma Ar flow 
rate: 18 L/min; dwell time: 50 ms. Standard gold, ruthenium, and rhodium solutions 
(concentration: 0, 0.2, 0.5, 1, 2, 5, 10, and 20 ppb) were prepared for the quantification. 
For the sample preparation for quantification of gold, Ruthenium, and Rhodium, Aqua 
regia (0.5 mL) was added to the sample solution (10 uL) and then the sample was diluted 
to 10 mL with de-ionized water. 
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5.4.5 ROMP reaction in water by using AuNP-HG2 
HG2 catalyst encapsulated 2 nm TTMA NPs (520 nM) was mixed with positively 
charged norbornene monomer (6 mM) in a final volume of 3 ml water. Polymerization 
reaction was monitored for various time intervals (1, 4, 6, 24 h) and THF GPC was used 
to calculate molecular weights and PDI values of polymers. 
5.4.6 Allyl carbamete bond cleavage reaction by using AuNP- Cp*Ru(cod)Cl 
Cp*Ru(cod)Cl encapsulated 2 nm TTMA NPs (194 nM) was mixed with caged 
Rhodamine 110 (220 µM) in a final volume of 1 ml water. Green fluorescence of 
Rhodamine 110 was observed as result of catalytic  allycarbamate deprotection reaction. 
UV absorbance of the Rhodamine 110  at a wavelength of 500 nm wavelength was 
monitor for reaction activity.  
5.4.7 Hydrogenation of sodium 4-vinylbenzenesulfonate via AuNP-Wilkinson 
catalyst 
Wilkinson catalyst encapsulated 2 nm TTMA NPs (23 µM, 1.2 mL) was mixed 
with sodium 4-vinylbenzenesulfonate (2.3 mg, 0.8 mL) in water under 3 atm H2 at room 
temperature. Reactions were monitored by NMR for various time intervals (1, 3, 6, 24, 48 
h).  For the reusability test, same conditions were applied. 
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5.4.8 Laser desorption/ionization mass spectrometry (LDI-MS) Instrumentation: 
The surface ligand coverage comparison was done using the previous reported 
LDI-MS method.20 The mixed disulphide ions were formed by TTMA/TMA ligand and 
original alkanethiol ligand. Higher amount of remaining alkanethiol ligands result in 
higher ion intensity ratio between the mixed disulphide ion and the intensity sum of 
TMA/TTMA ligand and mixed disulphide ion. The quantification data was acquired on a 
Bruker Autoflex III MALDI-TOF mass spectrometer (Bruker Daltonics, Bremen, 
Germany) (Autoflex III). Operating conditions were as follows: ion source 1 = 19.00 kV, 
ion source 2 = 16.60 kV, lens voltage = 8.44 kV, reflector voltage = 20.00 kV, reflector 
voltage 2 = 9.69 kV, pulsed ion extraction time = 10 ns, suppression = 100 Da, and at 
positive reflectron mode. Molecular ion and mixed disulphide ion from each molecule 
has been chosen as quantification ion in the data analysis, for example: TTMA (m/z 422), 
TMA (m/z 246), TTMA-C5 (m/z 524), and TMA-C5 (m/z 348). 40 mass spectra have 
been acquired for each sample, and each mass spectrum represents an average of 200 
laser shots. 
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Figure 5.11 GPC spectra of the polymers that were synthesized by ROMP in water at 
different time intervals (1, 4, 6, and 24 h).  
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Figure 5.12 GPC spectra of reactions that were performed using free catalysts in 
acetone/water mixture at different time intervals (1, 4, 6, and 24 h). 
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Figure 5.13 NMR spectra of the hydrogenation reactions in water at the different times 
(1, 3, 6, 24, and 48 h). 
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Figure 5.14 NMR spectra of hydrogenation reactions for recyclability test, yielding 4-
ethylbenzenesulfonate as the final product. All of samples were measured after 24 h 
reaction. 
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CHAPTER 6 
 
 
 
ALLOSTERICALLY-CONTROLLED BIOORTHOGONAL CATALYSIS IN 
CELLS USING NANOPARTICLE-EMBEDDED TRANSITION METAL 
CATALYSTS  
 
 
 
 
 
6.1 Introduction 
  Bioorthogonal chemistry1 is a promising strategy for the intracellular generation 
of molecules for therapeutic2 and imaging applications3 unattainable through naturally 
occurring bioprocesses.4 Transition metal catalysts (TMCs) are excellent candidates for 
use in bioorthogonal processes, 5  rapidly catalyzing transformations that cannot be 
performed via enzymatic processes. 6  However, the application of TMC-mediated 
reactions in living cells is challenging due to issues of biocompatibility, water solubility, 
catalyst stability, and rapid efflux of catalyst from living cells. 
Loading of TMCs into nanomaterial scaffolds can be used to provide water 
solubility and a protective environment for TMCs. Bradley et al.5c and Unciti-Broceta et 
al.6b used palladium-catalyst loaded polystyrene beads to catalyze reactions such as 
allylcarbamate cleavage and Suzuki-Miyaura coupling inside cells. The particles used in 
these studies, however, were far larger than normal proteins, creating potential 
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interference in cellular processes. Additionally, these particles did not provide the 
capability of allosteric regulation, a key component in cellular homeostasis.7  
In our research we have developed a family of gold nanoparticles (AuNPs)  based 
on ~2 nm core size8 that feature biomimetic size, possess diverse functional properties,9 
and are efficiently transport of into cells.10 We report here the use of the AuNP structural 
motif to encapsulate11 hydrophobic TMCs, providing NP_Ru (Figure 6.1) The resulting 
nanozymes12 feature surface functionality that can be reversibly functionalized using 
host-guest chemistry to provide NP_Ru_CB[7]. 13  Complexation of the monolayer 
terminal functionalities by cucurbit[7]uril (CB[7])14 in this system blocks access to the 
catalytic site, resulting in essentially complete inhibition of catalytic activity. The 
gatekeeper molecules15 can then be released from the AuNPs using competitive guests,16 
restoring catalytic activity (Figure 6.1). The efficacy of this system was demonstrated in 
solution and in cells through the gated generation of a fluorophore through deallylation of 
a non-fluorescent precursor. 
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Figure 6.1 Bioorthogonal nanozyme. (a) Particles used in study (b) Endosomal uptake of 
nanozymes. (c) Intracellular catalysis with NP_Ru. (d) CB[7] complexation with the 
ligand headgroup to provide NR_Ru_CB[7] inhibits catalyst activity (e) Nanozyme 
activity is restored through addition of the competitive guest ADA (f) Structures of the 
NP platform, CB[7] gatekeeper, and ADA. (g) Structures of the non-fluorescent substrate, 
fluorescent product, and embedded catalyst  
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6.2 Results and discussion 
6.2.1 Encapsulation of ruthenium catalysts in nanozymes 
We used AuNPs with core diameters of ~2 nm as the scaffold for our catalysts, 
with the goal of creating protein-sized systems with functional monolayers. The 
monolayer coverage of the NP nanoreactor scaffold features three crucial components: 1) 
a hydrophobic alkane segment for catalyst encapsulation, 2) a tetra(ethylene glycol) unit 
to provide biocompatibility,17 and 3) a dimethylbenzylammonium group to impart water 
solubility and bind the non-toxic CB[7] gatekeeper (Figure 6.1d).18  
We chose ruthenium-catalyzed deallylation19 as a model bioorthogonal process. 
To this end, we immobilized [Cp*Ru(cod)Cl] (Cp* = pentamethylcyclopentadienyl, cod 
= 1,5-cyclooctadiene)  in the hydrophobic portion of the AuNP monolayer to provide 
NP_Ru. Transmission electron microscopy (TEM) images of the AuNPs before and after 
encapsulation of the catalyst indicated that no aggregation or decomposition of AuNP 
structure occurred after encapsulation (Figure 6.2), a result that was confirmed by 
dynamic light scattering. The amount of catalyst relative to AuNP was quantified using 
inductively coupled plasma mass spectrometry (ICP-MS, Figure 6.3)20 of 101Ru relative 
to 197Au, with 42 ± 3 catalyst molecules encapsulated per AuNP. 
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Figure 6.2 TEM images of benzyl-AuNP with (a) without (b) encapsulation of the 
catalysts. 
 
 
Figure 6.3 Ruthenium amount in the nanozyme using ICP-MS measurement. 
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6.2.2 Catalytic efficacy of nanozymes in water 
The catalytic efficacy of the NP_Ru nanozymes in solution was assessed using 
the allylcarbamate cleavage of bis-N,N’-allyloxycarbonyl rhodamine 110 (Figure 6.1e). 
After 24 h bright fluorescence was observed using the nanozymes (Figure 6.4a). As 
expected no reaction occurred with the control particle that lacked embedded catalysts 
(Figure 6.5). Likewise, no catalysis was observed [Cp*Ru(cod)Cl] alone due to lack of 
aqueous solubility. 
 
Figure 6.4 Catalytic activity of nanozymes. (a) Fluorescence generation by NP_Ru and 
NP_Ru_CB[7] and (b) activity after adding ADA, (c) The reaction rates of the nanozyme 
and the nanozyme-CB before and after adding ADA (d) Photo of the reaction mixture 
with NP_Ru and NP_Ru_CB[7] under UV light. 
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Figure 6.5 Reaction mixtures including (a) the nanozyme and caged Rhodamine 110 and 
(b) Benzyl-AuNP and  caged Rhodamine 110 after 24 h. 
 
6.2.3 Inhibition mechanism of the nanozymes 
The analogy between allosteric regulation of the nanozymes and their enzyme 
counterparts was explored through kinetic analysis of the nanozymes using Lineweaver–
Burk analysis (LBA). 21  These studies indicate that CB[7] complexation results in 
competitive inhibition of reactor activity (Figure 6.6 and 6.7), presumably by blocking 
access to the [Cp*Ru(cod)Cl] "active site".  Little change in activity was observed for 
CB[7]:NPs ratios greater than ~80:1, consistent with the ITC results (Figure 6.8, 6.9, 
6.10). Likewise, the value of Ki from the LBA (11.4±4.3 mM) is essentially identical to 
the affinity obtained by ITC (11.3±2.4 mM). Taken together, these studies demonstrate 
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the direct correlation between CB[7]-AuNP equilibrium binding processes and kinetic 
behavior of the nanozyme. 
 
Figure 6.6 Lineweaver-Burk plot. Kinetic studies of NP_Ru and NR_Ru_CB[7] indicate 
that CB[7] inhibits catalyst activity through a competitive inhibition mechanism, with 
CB[7] affinity and stoichiometry consistent with ITC binding studies. 
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Figure 6.7 The dependence of reaction rates on the concentration of the substrates (a,0 
µM; b, 4 µM; c, 16 µM; and d, 80 µM). (e) The fitting curve of the reaction rate vs. 
concentration of the substrates 
	  167 
 
Figure 6.8 The dependence of reaction rate on the concentration of CB[7]. 
 
 
Figure 6.9 The reaction rate titration curve 
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Figure 6.10 ITC titration of CB[7]s into the nanozyme solution. The circles represent the 
integrated heat changes during complex formation and the lines represent the curve fit to 
the binding isotherm. 
 
6.2.4 Cellular uptake of the nanozymes and their cytotoxicity 
Having characterized the activity and gating of NP-Ru/NP_Ru_CB[7] catalysis 
in solution, we next studied the intracellular behavior of these nanozymes using HeLa 
cells. The cellular uptake of the nanozymes was quantified by tracking [197Au] using ICP-
MS, with NP_Ru_CB[7] particles demonstrating a slightly more efficient (1.7-fold 
greater) uptake than uncomplexed NR-Ru (Figure 6.11). Significantly, little to no 
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toxicity was observed at the concentrations used for our studies with NR, NR_Ru, or 
NR_Ru_CB[7]. (Figure 6.12). 
 
Figure 6.11 Nanozyme uptake assay by tracking the gold amount through ICP-MS.   
 
 
 
Figure 6.12 Cytotoxicity of the nanozyme with and without the catalyst.   
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6.2.5 Catlytic activity of the nanozymes inside the living cells 
We then probed the catalytic activity of the nanozymes inside the living cells. 
HeLa cells were incubated with the nanozyme for 24 h and then washed multiple times to 
remove adsorbed particles on the cell surface. Fresh media containing the substrate was 
added, followed by 24 h incubation and washing. As shown in Figure 5.13a, flow 
cytometry indicated that there was a significant increase in fluorescence with NR_Ru 
relative to the control NR. Confocal microscopy (Figure 6.13d) showed that the cells 
treated with NR_Ru had bright punctate fluorescence. This fluorescence co-localized 
with LysoTracker® (Figure 6.14), indicating that the deallylation reaction occurred in the 
endosomes. This outcome is expected given the endosomal uptake pathway22 previously 
observed for similar nanoparticles, coupled with the limited membrane permeability of 
the cleaved dye.23 
We next investigated the intracellular gating of the nanozyme by CB[7] 
complexation. Flow cytometry showed that the NR_Ru_CB[7] particles were completely 
inhibited, indicating intracellular stability of the complexes (Figure 6.13a). Treatment 
with ADA (400 mM) restored nanozyme activity, with even higher activity observed in 
the cells after treatment with ADA than was observed with NR_Ru (Figure 6.13b). This 
increased catalytic efficiency is echoed in the micrograph (Figure 5.13f) and potentially 
arises from enhanced protection of the catalyst by the CB[7] coverage.    
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Figure 6.13 Triggered allylcarbamate cleavage in living cells using gated nanozymes. (a) 
Flow cytometry of NP_Ru and controls  (b) Recovery of catalysis through addition of 
ADA to NP_Ru_CB[7] treated cells. (c-f) Confocal microscopy images of HeLa cells 
showing the supramolecularly regulated intracellular chemical reactions (scale bars = 10 
µm)  
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Figure 6.14 The confocal images of the cell treated with the nanozymes, substrates, and 
lysotracker (a); the nanozyme-bound-CB[7], substrate, ADA, and lysotracker (b). 
 
6.3 Summary and future outlook  
In conclusion, we have described the fabrication of a AuNP based, bioorthogonal 
nanozyme. These catalysts were built upon a platform featuring biomimetic size and 
surface functionality. Host-guest interactions of CB[7] molecules with the benzyl 
headgroup of the AuNP ligands on these particles provided allosteric control of the 
nanozyme activity, providing an efficient and reversible means of regulating catalysis.  
Future studies will explore the use of this artificial enzyme to control the 
bioprocesse or treatment of many enzyme-involved diseases. The adjusted steric 
hindrance from the complexation of host-guest can be used for selective reactions, 
targeting the certain sized substrates. Taken together, this system integrates biomimetic 
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and bioorthogonal design elements to provide a new tool for potential applications in 
imaging and therapeutics.  
 
6.4 Synthesis of materials and experimental methods  
6.4.1 Synthesis of ligand and fabrication of nanoparticle 
 
6.4.1.1 Synthesis of the benzyl ligand 
 
Figure 6.15 Synthetic scheme of the benzyl ligand for the functionalization of the 
nanoparticle. 
6.4.1.2 General procedure: 
Compound 2: 11-bromo-1-undecanol (1, 8.22 g, 32.74 mmol) was dissolved in 1:1 
ethanol/toluene mixture (150 ml). Triphenylmethanethiol (10.86 g, 39.29 mmol) 
dissolved in 1:1 ethanol/toluene (50 ml) was added to 11-bromo-1-undecanol in solution. 
Then NaOH (1.96 g, 49.11 mmol) dissolved in 3 ml water was slowly added to the 
mixture. The reaction mixture was stirred for 24 h at 50°C. Upon completion, the reaction 
mixture was extracted with a saturated solution of NaHCO3 twice. The organic layer was 
extracted, dried over Na2SO4, and concentrated by evaporation of the solvent. The crude 
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product was purified by column chromatography over silica gel using hexane/ethyl 
acetate (1:1, v/v) as the eluent. The solvent was removed in vacuum to obtain compound 
2 as colorless oil (Yield 13.88 g, 95%). 
 
 
Figure 6.16 1H NMR spectrum (400 MHz) of compound 2 in CDCl3 (D, 99.8%). 
 
Compound 3: Compound 2 (13.88 g, 31.1 mmol) in dry dichloromethane (DCM, 200 
ml) was mixed with triethylamine (4.72g, 6.48 mL, 46.65 mmol), followed by dropwise 
addition of methanesulfonyl chloride (3.92 g, 2.65mL, 34.21 mmol) in ice bath. After 30 
min the reaction mixture was warmed up to room temperature and stirred overnight. After 
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the reaction was completed (according to thin layer chromatography; TLC), solvent was 
evaporated. The compound was again diluted with DCM and extracted with 0.1 M HCl 
twice. The organic layer was collected, treated with a saturated solution of NaHCO3, and 
washed three times. Following extraction, the organic layer was dried over Na2SO4 and 
concentrated at reduced pressure. The crude product was purified by column 
chromatography over silica gel using hexane/ethyl acetate (1:1, v/v) as the eluent. Solvent 
was removed in vacuum to obtain mesylated compound as light yellow oil (Yield 15 g, 
92%). To synthesize compound 3, NaOH (1.37 g, 34.3 mmol) solution (1 mL) was added 
to 99.24 mL of tetraethyleneglycol (111.15 g, 57.22 mmol) and stirred for 2 h at 80°C. To 
this reaction mixture, 15 g of 11-(tritylthio)undecyl methanesulfonate was added and 
stirred for 24 h at 100°C. The product was extracted in hexane/ethyl acetate (4:1, v/v) six 
times. Then, the organic layer was concentrated at reduced pressure and the crude 
product was purified by column chromatography over silica gel using ethyl acetate as the 
eluent. The solvent was removed in vacuum to obtain compound 3 as light yellow oil 
(Yield 15.28 g, 68%). 
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Figure 6.17 1H NMR spectrum (400 MHz) of compound 3 in CDCl3 (D, 99.8%). 
 
Compound 4: Triethylamine (3.26g, 4.49 mL, 32.2 mmol) was added to compound 3 (10 
g, 16.1 mmol) in dry DCM (80 ml) in an ice bath. Methanesulfonyl chloride (2.77 g, 1.87 
mL, 24.1 mmol) was added dropwise to the reaction mixture in an ice bath. After 30 min 
the reaction mixture was warmed up to room temperature and stirred overnight. The 
reaction mixture was worked up and the organic layer was extracted. The extracted DCM 
layer was dried over Na2SO4 and concentrated at reduced pressure. The crude product 
was purified by column chromatography over silica gel using ethyl acetate as the eluent. 
Solvent was removed in vacuum to obtain compound 4 as light yellow oil (Yield 10.7 g, 
95 %).  
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Figure 6.18 1H NMR spectrum (400 MHz) of compound 4 in CDCl3 (D, 99.8%). 
 
Compound 5: Compound 4 (1.075 g, 1.53 mmol) was added to dimethylbenzylamine 
(0.62 g, 0.7 ml, 4.6 mmol) in ethanol (8 ml). The reaction mixture was stirred at 40°C for 
48 h. After evaporating ethanol at reduced pressure, the light yellow residue was purified 
by successive washings with hexane (four times) and hexane/diethylether (1:1 v/v, six 
times) and then dried under high vacuum. The product formation was around 100% and 
the product was confirmed by NMR.  
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Figure 6.19 1H NMR spectrum (400 MHz) of compound 5 in CDCl3 (D, 99.8%). 
 
Compound 6: An excess of trifluoroacetic acid (TFA, 20 equivalents, 3.69 g, 2.5 mL, 
32.4 mmol) was added to compound 5 (1.2 g, 1.62 mmol) in dry DCM (5 ml). The color 
of the solution was turned to yellow upon addition of TFA. Then, triisopropylsilane 
(TIPS, three equivalents, 0.77g, 1 mL, 4.86 mmol) was added to the reaction mixture. 
The reaction mixture was stirred 5 hr under N2 at room temperature. The solvent, most of 
TFA, and TIPS were evaporated under reduced pressure. The yellow residue was purified 
by hexane washings (four times) and dried under high vacuum. The final product 
formation was around 100% and the structure of compound 6 was confirmed by NMR. 
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Figure 6.20 1H NMR spectrum (400 MHz) of benzyl ligand in CDCl3 (D, 99.8%). 
 
6.4.1.3 Synthesis of benzyl-ligand-protected gold nanoparticle (AuNP)  
First, Brust-Schiffrin two-phase synthesis method was used to synthesize pentanethiol-
coated AuNPs with core diameter ca. 2 nm.24 Murray place-exchange method25 was 
followed to obtain the benzyl-ligand-protected AuNPs. Pentanethiol-conjugated AuNPs 
(10 mg) and thiol ligand (compound 5) (30 mg) were dissolved in a mixture of dry DCM 
(3 ml) and methanol (1 ml) and stirred under N2 atmosphere for 3 days at room 
temperature. The DCM was removed under reduced pressure and the resulting precipitate 
was washed with hexane three times and DCM twice. Then the precipitate was dissolved 
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in distilled water and dialyzed for three days (membrane molecular weight cut-off 
=10,000) to remove excess ligands, pentanethiol, acetic acid, and other salts present in 
the nanoparticle solution. After dialysis, the particle was lyophilized to yield a solid 
brownish product. The particles were then redispersed in deionized water. 1H NMR-
spectra in D2O showed substantial broadening of the proton peaks with no sign of free 
ligands. The presence of ligands was also confirmed by mass spectroscopy. 
 
Figure 6.21 1H NMR spectrum (400 MHz) of benzyl-AuNPs in D2O (D, 99.8%). 
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6.4.1.4 Mass spectrometric characterization of ligand composition 
Matrix assisted laser desorption/ionization mass spectroscopy (MALDI-MS) has been 
performed to characterize the surface ligand on the Benzyl-AuNP.26 A saturated α-
Cyano-4-hydroxycinnamic acid (α-CHCA) stock solution was prepared in 70% 
acetonitrile, 30% H2O, and 0.1% trifluoroacetic acid. An equal volume of 2 µM NP 
solution was added to the matrix stock solution. 2.5 µL of this mixture was applied to the 
sample carrier, and then the MALDI-MS analysis was performed on a Bruker Autoflex 
III mass spectrometer. The molecular ions (MH+, m/z =498) were detected, and the 
disulfide ion formed by the benzyl ligand and the original pentanethiol was also detected 
at m/z 600.  
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Figure 6.22 MALDI-MS spectrum of benzyl-AuNP. 
 
6.4.2 Experimental methods 
6.4.2.1 Catalyst encapsulation into the monolayer of AuNPs 
The catalyst, [Cp*Ru(cod)Cl], and the AuNP were dissolved in an acetone/water mixture 
and then the acetone was slowly removed by evaporation. During the evaporation the 
catalyst was encapsulated in the particle monolayer, with excess catalyst precipitating and 
removed by filtration. The AuNPs were purified by multiple filtrations and dialyzed 
against water to remove free catalysts. The amount of encapsulated catalyst was 
measured by ICP-MS by tracking 101Ru relative to 197Au.  
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6.4.2.2 Kinetic studies of nanozymes using Lineweaver–Burk analysis 
In the titration of the reaction rate of the nanozyme using the CB[7], 400 nM of the 
AuNPs, 20 µM of the substrate, and set molar ratios of CB[7]s were used in DI water. For 
the Lineweaver-Burk analysis, 400 nM of the AuNPs, 2, 4, 20, 40, and 80 µM of the 
substrate, and 0, 4, 16, and 80 µM of CB[7] were used. The concentration of the products 
was calculated based on the fluorescence standard curve of Rhodamine 110 (Figure 5.23).  
 
Figure 6.23 The standard curve of the Rhodamine 110 for the calculation of the reaction 
rate. 
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6.4.2.3 Catalytic activity of the nanozymes inside living cells 
HeLa cells were grown in a cell culture flask using low-glucose Dulbecco’s modified 
Eagle medium supplemented with 10% fetal bovine serum at 37°C in a humidified 
atmosphere of 5% CO2. For confocal and flow cytometry analysis, HeLa cells were 
seeded at 20,000 and 80,000 cells in 0.5 mL per well in 24-well plates 24 h prior to the 
experiment. During the experiment old media were replaced by 200 nM of the 
nanozymes and the nanozyme-bound CB[7] in serum-containing media and the cells 
were incubated for 24 h and washed with PBS buffer three times. 100 µM of the 
substrates were then added to the cells and incubated for 24 h. The cells were then 
washed with PBS three times. For the cytometry, a Becton Dickinson LSR cytometer was 
used. A total of 10,000 events per sample were analyzed. A530/30 bandpass filter (FITC) 
was used for rhodamine 110. Confocal microscopy images were obtained on a Zeiss LSM 
510 Meta microscope by using a 63× objective. The settings of the confocal microscope 
were as follows unless otherwise specified: green channel: λex=488 nm and λem=BP 505-
530 nm; red channel: λex=543 nm and λem=LP 650 nm. Emission filters: BP=band pass, 
LP=high pass. LysoTracker® Red DND-99 was obtained from Invitrogen. 100 nM of 
LysoTracker® was incubated with cells for 30 min prior to the microscopy experiments. 
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